{"name":"Johnson & Johnson","slug":"johnson-johnson","ticker":"JNJ","exchange":"NYSE","domain":"jnj.com","description":"Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 48 on the 2025 Fortune 500 list of the largest United States corporations. In 2025, the company was ranked 42nd in the Forbes Global 2000. Johnson & Johnson has a global workforce of approximately 138,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato. Johnson & Johnson is one of the world's most valuable companies and is one of only two U.S.-based companies that has a prime credit rating of AAA.","hq":"New Brunswick, NJ","founded":0,"employees":"138200","ceo":"Joaquin Duato","sector":"Big Pharma","stockPrice":237.67,"stockChange":-0.74,"stockChangePercent":-0.31,"marketCap":"$572.8B","metrics":{"revenue":94193000000,"revenueGrowth":9.1,"grossMargin":68.1,"rdSpend":109000000,"netIncome":26804000000,"cash":20102000640,"dividendYield":2.18,"peRatio":21.5,"fiscalYear":"FY2025"},"revenueBreakdown":[{"name":"Darzalex","genericName":"daratumumab","slug":"daratumumab","revenue":11800000000,"yoyGrowth":0,"percentOfTotal":28.1},{"name":"Stelara","genericName":"ustekinumab","slug":"ustekinumab","revenue":9500000000,"yoyGrowth":0,"percentOfTotal":22.6},{"name":"Remicade","genericName":"INFLIXIMAB","slug":"chembl-chembl1201581","revenue":4200000000,"yoyGrowth":0,"percentOfTotal":10},{"name":"Invega Sustenna","genericName":"PALIPERIDONE PALMITATE","slug":"paliperidone-palmitate","revenue":3800000000,"yoyGrowth":0,"percentOfTotal":9},{"name":"Tremfya","genericName":"GUSELKUMAB","slug":"guselkumab","revenue":3600000000,"yoyGrowth":0,"percentOfTotal":8.6},{"name":"Erleada","genericName":"apalutamide","slug":"apalutamide","revenue":2600000000,"yoyGrowth":0,"percentOfTotal":6.2},{"name":"Zytiga","genericName":"abiraterone-acetate","slug":"abiraterone-acetate","revenue":1500000000,"yoyGrowth":0,"percentOfTotal":3.6},{"name":"Carvykti","genericName":"ciltacabtagene autoleucel","slug":"ciltacabtagene-autoleucel","revenue":1100000000,"yoyGrowth":0,"percentOfTotal":2.6},{"name":"Invokana","genericName":"CANAGLIFLOZIN","slug":"canagliflozin","revenue":800000000,"yoyGrowth":0,"percentOfTotal":1.9},{"name":"Rybrevant","genericName":"AMIVANTAMAB","slug":"amivantamab","revenue":800000000,"yoyGrowth":0,"percentOfTotal":1.9},{"name":"Spravato","genericName":"ESKETAMINE","slug":"esketamine","revenue":800000000,"yoyGrowth":0,"percentOfTotal":1.9},{"name":"Sirturo","genericName":"bedaquiline","slug":"bedaquiline","revenue":400000000,"yoyGrowth":0,"percentOfTotal":1},{"name":"Bcmaxcd3","genericName":"TECLISTAMAB","slug":"teclistamab","revenue":400000000,"yoyGrowth":0,"percentOfTotal":1},{"name":"Talvey","genericName":"TALQUETAMAB","slug":"talquetamab","revenue":400000000,"yoyGrowth":0,"percentOfTotal":1},{"name":"Balversa","genericName":"ERDAFITINIB","slug":"erdafitinib","revenue":300000000,"yoyGrowth":0,"percentOfTotal":0.7}],"timeline":[{"date":"1945-01-01","label":"Sulfabenzid first approved","drug":"Sulfabenzid","drugSlug":"sulfabenzamide","type":"approval","sentiment":"positive"},{"date":"1946-01-01","label":"Benadryl first approved","drug":"Benadryl","drugSlug":"diphenhydramine","type":"approval","sentiment":"positive"},{"date":"1947-01-01","label":"Synestrol first approved","drug":"Synestrol","drugSlug":"dienestrol","type":"approval","sentiment":"positive"},{"date":"1958-01-01","label":"Parafon Forte Dsc first approved","drug":"Parafon Forte Dsc","drugSlug":"chlorzoxazone","type":"approval","sentiment":"positive"},{"date":"1962-01-01","label":"Grifulvin V first approved","drug":"Grifulvin V","drugSlug":"griseofulvin","type":"approval","sentiment":"positive"},{"date":"1962-01-01","label":"Micronor first approved","drug":"Micronor","drugSlug":"norethisterone","type":"approval","sentiment":"positive"},{"date":"1967-04-12","label":"Haldol first approved","drug":"Haldol","drugSlug":"haloperidol","type":"approval","sentiment":"positive"},{"date":"1968-01-01","label":"Duragesic first approved","drug":"Duragesic","drugSlug":"fentanyl","type":"approval","sentiment":"positive"},{"date":"1974-01-01","label":"Monistat first approved","drug":"Monistat","drugSlug":"miconazole","type":"approval","sentiment":"positive"},{"date":"1976-12-28","label":"Imodium first approved","drug":"Imodium","drugSlug":"loperamide","type":"approval","sentiment":"positive"},{"date":"1978-01-01","label":"Motilium first approved","drug":"Motilium","drugSlug":"domperidone","type":"approval","sentiment":"positive"},{"date":"1981-06-26","label":"Nizoral first approved","drug":"Nizoral","drugSlug":"ketoconazole","type":"approval","sentiment":"positive"},{"date":"1986-01-01","label":"Haldol first approved","drug":"Haldol","drugSlug":"haloperidol-decanoate","type":"approval","sentiment":"positive"},{"date":"1993-01-01","label":"Reopro first approved","drug":"Reopro","drugSlug":"abciximab","type":"approval","sentiment":"positive"},{"date":"1993-12-29","label":"Risperdal first approved","drug":"Risperdal","drugSlug":"risperidone","type":"approval","sentiment":"positive"},{"date":"1998-01-01","label":"Remicade first approved","drug":"Remicade","drugSlug":"chembl-chembl1201581","type":"approval","sentiment":"positive"},{"date":"2001-01-01","label":"Axert first approved","drug":"Axert","drugSlug":"almotriptan","type":"approval","sentiment":"positive"},{"date":"2001-01-01","label":"Razadyne first approved","drug":"Razadyne","drugSlug":"galantamine","type":"approval","sentiment":"positive"},{"date":"2006-01-01","label":"Prezista first approved","drug":"Prezista","drugSlug":"darunavir","type":"approval","sentiment":"positive"},{"date":"2008-01-01","label":"Intelence first approved","drug":"Intelence","drugSlug":"etravirine","type":"approval","sentiment":"positive"},{"date":"2009-01-01","label":"Invega Sustenna first approved","drug":"Invega Sustenna","drugSlug":"paliperidone-palmitate","type":"approval","sentiment":"positive"},{"date":"2011-01-01","label":"Zytiga first approved","drug":"Zytiga","drugSlug":"abiraterone-acetate","type":"approval","sentiment":"positive"},{"date":"2012-01-01","label":"Sirturo first approved","drug":"Sirturo","drugSlug":"bedaquiline","type":"approval","sentiment":"positive"},{"date":"2013-01-01","label":"Invokana first approved","drug":"Invokana","drugSlug":"canagliflozin","type":"approval","sentiment":"positive"},{"date":"2015-01-01","label":"Darzalex first approved","drug":"Darzalex","drugSlug":"daratumumab","type":"approval","sentiment":"positive"},{"date":"2015-01-01","label":"Yondelis first approved","drug":"Yondelis","drugSlug":"trabectedin","type":"approval","sentiment":"positive"},{"date":"2017-01-01","label":"Tremfya first approved","drug":"Tremfya","drugSlug":"guselkumab","type":"approval","sentiment":"positive"},{"date":"2018-01-01","label":"Erleada first approved","drug":"Erleada","drugSlug":"apalutamide","type":"approval","sentiment":"positive"},{"date":"2019-01-01","label":"Spravato first approved","drug":"Spravato","drugSlug":"esketamine","type":"approval","sentiment":"positive"},{"date":"2019-01-01","label":"Balversa first approved","drug":"Balversa","drugSlug":"erdafitinib","type":"approval","sentiment":"positive"},{"date":"2021-01-01","label":"Rybrevant first approved","drug":"Rybrevant","drugSlug":"amivantamab","type":"approval","sentiment":"positive"},{"date":"2022-01-01","label":"Bcmaxcd3 first approved","drug":"Bcmaxcd3","drugSlug":"teclistamab","type":"approval","sentiment":"positive"},{"date":"2023-01-01","label":"Talvey first approved","drug":"Talvey","drugSlug":"talquetamab","type":"approval","sentiment":"positive"},{"date":"2025-01-01","label":"Imaavy first approved","drug":"Imaavy","drugSlug":"nipocalimab","type":"approval","sentiment":"positive"},{"date":"2026-06-26","label":"Risperdal patent expiry (Formulation)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-09-26","label":"Risperdal patent expiry (Method of Use)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2026-09-26","label":"Risperdal patent expiry (Formulation)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-11-01","label":"Stelara Phase 2 readout (Type 1 Diabetes Mellitus)","drug":"Stelara","drugSlug":"ustekinumab","type":"phase3_readout","sentiment":"neutral"},{"date":"2026-11-05","label":"Risperdal patent expiry (Formulation)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2026-12-31","label":"Rybrevant PHASE1 readout","drug":"Rybrevant","drugSlug":"amivantamab","type":"phase3_readout","sentiment":"neutral"},{"date":"2026-12-31","label":"Duragesic Phase 3 readout (Opioid Use Disorder)","drug":"Duragesic","drugSlug":"fentanyl","type":"phase3_readout","sentiment":"neutral"},{"date":"2026-12-31","label":"Motilium Phase 2 readout (Disorder of Consciousness)","drug":"Motilium","drugSlug":"domperidone","type":"phase3_readout","sentiment":"neutral"},{"date":"2027-01-25","label":"Duragesic patent expiry (Formulation)","drug":"Duragesic","drugSlug":"fentanyl","type":"patent_expiry","sentiment":"negative"},{"date":"2027-01-25","label":"Duragesic patent expiry (Formulation)","drug":"Duragesic","drugSlug":"fentanyl","type":"patent_expiry","sentiment":"negative"},{"date":"2027-01-25","label":"Duragesic patent expiry (Formulation)","drug":"Duragesic","drugSlug":"fentanyl","type":"patent_expiry","sentiment":"negative"},{"date":"2027-01-25","label":"Duragesic patent expiry (Formulation)","drug":"Duragesic","drugSlug":"fentanyl","type":"patent_expiry","sentiment":"negative"},{"date":"2027-01-25","label":"Duragesic patent expiry (Formulation)","drug":"Duragesic","drugSlug":"fentanyl","type":"patent_expiry","sentiment":"negative"},{"date":"2027-01-25","label":"Duragesic patent expiry (Formulation)","drug":"Duragesic","drugSlug":"fentanyl","type":"patent_expiry","sentiment":"negative"},{"date":"2027-01-25","label":"Duragesic patent expiry (Formulation)","drug":"Duragesic","drugSlug":"fentanyl","type":"patent_expiry","sentiment":"negative"},{"date":"2027-01-25","label":"Duragesic patent expiry (Formulation)","drug":"Duragesic","drugSlug":"fentanyl","type":"patent_expiry","sentiment":"negative"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-03-31","label":"Balversa PHASE2 readout","drug":"Balversa","drugSlug":"erdafitinib","type":"phase3_readout","sentiment":"neutral"},{"date":"2027-04-01","label":"Nizoral Phase 3 readout (Intracerebral Hemorrhage, Atrial Fibrillation)","drug":"Nizoral","drugSlug":"ketoconazole","type":"phase3_readout","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-05-28","label":"Bcmaxcd3 PHASE1,PHASE2 readout","drug":"Bcmaxcd3","drugSlug":"teclistamab","type":"phase3_readout","sentiment":"neutral"},{"date":"2027-05-28","label":"Bcmaxcd3 PHASE2 readout","drug":"Bcmaxcd3","drugSlug":"teclistamab","type":"phase3_readout","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-20","label":"Talvey PHASE1 readout","drug":"Talvey","drugSlug":"talquetamab","type":"phase3_readout","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-31","label":"Motilium Phase 3 readout (Digestive System Disorder, Dyspepsia)","drug":"Motilium","drugSlug":"domperidone","type":"phase3_readout","sentiment":"neutral"},{"date":"2027-11-12","label":"Risperdal patent expiry (Formulation)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2027-11-12","label":"Risperdal patent expiry (Formulation)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2027-11-16","label":"Topamax patent expiry (Formulation)","drug":"Topamax","drugSlug":"topiramate","type":"patent_expiry","sentiment":"negative"},{"date":"2027-11-16","label":"Topamax patent expiry (Formulation)","drug":"Topamax","drugSlug":"topiramate","type":"patent_expiry","sentiment":"negative"},{"date":"2027-11-16","label":"Topamax patent expiry (Formulation)","drug":"Topamax","drugSlug":"topiramate","type":"patent_expiry","sentiment":"negative"},{"date":"2027-11-16","label":"Topamax patent expiry (Method of Use)","drug":"Topamax","drugSlug":"topiramate","type":"patent_expiry","sentiment":"negative"},{"date":"2027-11-16","label":"Topamax patent expiry (Formulation)","drug":"Topamax","drugSlug":"topiramate","type":"patent_expiry","sentiment":"negative"},{"date":"2027-11-16","label":"Topamax patent expiry (Formulation)","drug":"Topamax","drugSlug":"topiramate","type":"patent_expiry","sentiment":"negative"},{"date":"2027-11-16","label":"Topamax patent expiry (Formulation)","drug":"Topamax","drugSlug":"topiramate","type":"patent_expiry","sentiment":"negative"},{"date":"2027-11-16","label":"Topamax patent expiry (Formulation)","drug":"Topamax","drugSlug":"topiramate","type":"patent_expiry","sentiment":"negative"},{"date":"2027-11-16","label":"Topamax patent expiry (Formulation)","drug":"Topamax","drugSlug":"topiramate","type":"patent_expiry","sentiment":"negative"},{"date":"2027-12-31","label":"Erleada PHASE3 readout","drug":"Erleada","drugSlug":"apalutamide","type":"phase3_readout","sentiment":"neutral"},{"date":"2027-12-31","label":"Erleada PHASE3 readout","drug":"Erleada","drugSlug":"apalutamide","type":"phase3_readout","sentiment":"neutral"},{"date":"2028-02-13","label":"Risperdal patent expiry (Method of Use)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2028-02-13","label":"Risperdal patent expiry (Method of Use)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2028-02-13","label":"Risperdal patent expiry (Method of Use)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2028-02-13","label":"Risperdal patent expiry (Formulation)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2028-02-13","label":"Risperdal patent expiry (Formulation)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2028-02-13","label":"Risperdal patent expiry (Formulation)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2028-03-15","label":"Stelara Phase 3 readout (Crohn Disease, Colitis, Ulcerative)","drug":"Stelara","drugSlug":"ustekinumab","type":"phase3_readout","sentiment":"neutral"},{"date":"2028-03-31","label":"TALVEY Phase 3 readout (Multiple Myeloma)","drug":"TALVEY","drugSlug":"talquetamab-tgvs","type":"phase3_readout","sentiment":"neutral"},{"date":"2028-03-31","label":"TECVAYLI Phase 3 readout (Multiple Myeloma)","drug":"TECVAYLI","drugSlug":"teclistamab-cqyv","type":"phase3_readout","sentiment":"neutral"},{"date":"2028-04-04","label":"Topamax patent expiry (Formulation)","drug":"Topamax","drugSlug":"topiramate","type":"patent_expiry","sentiment":"negative"},{"date":"2028-07-01","label":"Imodium Phase 3 readout (LARS - Low Anterior Resection Syndrome, Rectal Cancer Surgery)","drug":"Imodium","drugSlug":"loperamide","type":"phase3_readout","sentiment":"neutral"},{"date":"2028-11-02","label":"Sirturo PHASE2 readout","drug":"Sirturo","drugSlug":"bedaquiline","type":"phase3_readout","sentiment":"neutral"},{"date":"2028-12-31","label":"Topamax Phase 3 readout (Non-Convulsive Status Epilepticus)","drug":"Topamax","drugSlug":"topiramate","type":"phase3_readout","sentiment":"neutral"},{"date":"2029-03-30","label":"Talvey PHASE2 readout","drug":"Talvey","drugSlug":"talquetamab","type":"phase3_readout","sentiment":"neutral"},{"date":"2029-03-30","label":"Imaavy PHASE3 readout","drug":"Imaavy","drugSlug":"nipocalimab","type":"phase3_readout","sentiment":"neutral"},{"date":"2029-06-18","label":"RYBREVANT Phase 3 readout (Squamous Cell Carcinoma of Head and Neck)","drug":"RYBREVANT","drugSlug":"amivantamab-vmjw","type":"phase3_readout","sentiment":"neutral"},{"date":"2029-07-01","label":"Motilium Phase 3 readout (Type 1 Diabetic)","drug":"Motilium","drugSlug":"domperidone","type":"phase3_readout","sentiment":"neutral"},{"date":"2029-12-01","label":"Stelara Phase 3 readout (Crohn's Disease, Inflammatory Bowel Diseases)","drug":"Stelara","drugSlug":"ustekinumab","type":"phase3_readout","sentiment":"neutral"},{"date":"2029-12-01","label":"Monistat Phase 3 readout (Crohn's Disease, Inflammatory Bowel Diseases)","drug":"Monistat","drugSlug":"miconazole","type":"phase3_readout","sentiment":"neutral"},{"date":"2030-04-27","label":"Duragesic patent expiry (Method of Use)","drug":"Duragesic","drugSlug":"fentanyl","type":"patent_expiry","sentiment":"negative"},{"date":"2030-04-27","label":"Duragesic patent expiry (Formulation)","drug":"Duragesic","drugSlug":"fentanyl","type":"patent_expiry","sentiment":"negative"},{"date":"2030-11-08","label":"Stelara Phase 3 readout (Moderate to Severe Plaque Psoriasis)","drug":"Stelara","drugSlug":"ustekinumab","type":"phase3_readout","sentiment":"neutral"},{"date":"2031-01-26","label":"Invega Sustenna patent expiry (Method of Use)","drug":"Invega Sustenna","drugSlug":"paliperidone-palmitate","type":"patent_expiry","sentiment":"negative"},{"date":"2031-02-28","label":"Benadryl Phase 3 readout (Lupus Nephritis)","drug":"Benadryl","drugSlug":"diphenhydramine","type":"phase3_readout","sentiment":"neutral"},{"date":"2031-05-31","label":"Risperdal patent expiry (Method of Use)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2031-05-31","label":"Risperdal patent expiry (Method of Use)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2031-05-31","label":"Risperdal patent expiry (Method of Use)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2031-05-31","label":"Risperdal patent expiry (Method of Use)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2031-05-31","label":"Risperdal patent expiry (Method of Use)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2031-05-31","label":"Risperdal patent expiry (Method of Use)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2031-05-31","label":"Risperdal patent expiry (Method of Use)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2031-05-31","label":"Risperdal patent expiry (Method of Use)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2031-05-31","label":"Risperdal patent expiry (Formulation)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2031-05-31","label":"Risperdal patent expiry (Formulation)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2031-05-31","label":"Risperdal patent expiry (Formulation)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2031-05-31","label":"Risperdal patent expiry (Formulation)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2031-05-31","label":"Risperdal patent expiry (Formulation)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2031-05-31","label":"Risperdal patent expiry (Formulation)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2032-04-10","label":"Risperdal patent expiry (Formulation)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2032-04-10","label":"Risperdal patent expiry (Formulation)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2032-04-10","label":"Risperdal patent expiry (Formulation)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2032-04-10","label":"Risperdal patent expiry (Formulation)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2032-04-10","label":"Risperdal patent expiry (Formulation)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2033-03-19","label":"Topamax patent expiry (Method of Use)","drug":"Topamax","drugSlug":"topiramate","type":"patent_expiry","sentiment":"negative"},{"date":"2033-03-19","label":"Topamax patent expiry (Formulation)","drug":"Topamax","drugSlug":"topiramate","type":"patent_expiry","sentiment":"negative"},{"date":"2033-03-19","label":"Topamax patent expiry (Formulation)","drug":"Topamax","drugSlug":"topiramate","type":"patent_expiry","sentiment":"negative"},{"date":"2033-03-19","label":"Topamax patent expiry (Formulation)","drug":"Topamax","drugSlug":"topiramate","type":"patent_expiry","sentiment":"negative"},{"date":"2033-03-19","label":"Topamax patent expiry (Formulation)","drug":"Topamax","drugSlug":"topiramate","type":"patent_expiry","sentiment":"negative"},{"date":"2033-04-05","label":"Risperdal patent expiry (Formulation)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2033-10-21","label":"Benadryl Phase 3 readout (Plasma Cell Myeloma)","drug":"Benadryl","drugSlug":"diphenhydramine","type":"phase3_readout","sentiment":"neutral"},{"date":"2034-02-17","label":"Xarelto patent expiry (Method of Use)","drug":"Xarelto","drugSlug":"rivaroxaban","type":"patent_expiry","sentiment":"negative"},{"date":"2034-08-17","label":"Xarelto patent expiry (Compound)","drug":"Xarelto","drugSlug":"rivaroxaban","type":"patent_expiry","sentiment":"negative"},{"date":"2038-10-26","label":"Invega Sustenna patent expiry (Method of Use)","drug":"Invega Sustenna","drugSlug":"paliperidone-palmitate","type":"patent_expiry","sentiment":"negative"},{"date":"2039-09-24","label":"Invega Sustenna patent expiry (Method of Use)","drug":"Invega Sustenna","drugSlug":"paliperidone-palmitate","type":"patent_expiry","sentiment":"negative"},{"date":"2040-08-21","label":"Topamax patent expiry (Method of Use)","drug":"Topamax","drugSlug":"topiramate","type":"patent_expiry","sentiment":"negative"},{"date":"2040-08-21","label":"Topamax patent expiry (Formulation)","drug":"Topamax","drugSlug":"topiramate","type":"patent_expiry","sentiment":"negative"},{"date":"2040-08-21","label":"Topamax patent expiry (Formulation)","drug":"Topamax","drugSlug":"topiramate","type":"patent_expiry","sentiment":"negative"},{"date":"2040-08-21","label":"Topamax patent expiry (Formulation)","drug":"Topamax","drugSlug":"topiramate","type":"patent_expiry","sentiment":"negative"},{"date":"2040-08-21","label":"Topamax patent expiry (Formulation)","drug":"Topamax","drugSlug":"topiramate","type":"patent_expiry","sentiment":"negative"},{"date":"2040-09-11","label":"Risperdal patent expiry (Formulation)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2040-09-11","label":"Risperdal patent expiry (Formulation)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2042-03-17","label":"Risperdal patent expiry (Method of Use)","drug":"Risperdal","drugSlug":"risperidone","type":"patent_expiry","sentiment":"negative"},{"date":"2028-06-01","label":"Risperdal patent cliff ($1.4B at risk)","drug":"Risperdal","type":"patent_expiry","sentiment":"negative"},{"date":"2023-06-01","label":"Duragesic patent cliff ($1.1B at risk)","drug":"Duragesic","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":22000000000,"percentOfTotal":52.4,"drugCount":21,"colorKey":"oncology","drugs":[{"name":"Darzalex","genericName":"daratumumab","slug":"daratumumab","indication":"Multiple myeloma","status":"marketed","revenue":11800000000},{"name":"Remicade","genericName":"INFLIXIMAB","slug":"chembl-chembl1201581","indication":"Ankylosing spondylitis","status":"marketed","revenue":4200000000},{"name":"Erleada","genericName":"apalutamide","slug":"apalutamide","indication":"Castration-resistant prostate cancer","status":"marketed","revenue":2600000000},{"name":"Zytiga","genericName":"abiraterone-acetate","slug":"abiraterone-acetate","indication":"Malignant tumor of prostate","status":"marketed","revenue":1500000000},{"name":"Rybrevant","genericName":"AMIVANTAMAB","slug":"amivantamab","indication":"Advanced or metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations","status":"marketed","revenue":800000000},{"name":"Bcmaxcd3","genericName":"TECLISTAMAB","slug":"teclistamab","indication":"Relapsed or Refractory Multiple Myeloma (Combination Therapy)","status":"marketed","revenue":400000000},{"name":"Talvey","genericName":"TALQUETAMAB","slug":"talquetamab","indication":"Relapsed or refractory multiple myeloma","status":"marketed","revenue":400000000},{"name":"Balversa","genericName":"ERDAFITINIB","slug":"erdafitinib","indication":"Locally advanced or metastatic urothelial carcinoma","status":"marketed","revenue":300000000},{"name":"Abiraterone Acetate","genericName":"ABIRATERONE","slug":"chembl-chembl254328","indication":"Metastatic castration-resistant prostate cancer (CRPC)","status":"marketed"},{"name":"Duragesic","genericName":"fentanyl","slug":"fentanyl","indication":"Acute postoperative pain","status":"marketed"},{"name":"Epoetin alfa 3 times weekly /once weekly","genericName":"Epoetin alfa 3 times weekly /once weekly","slug":"epoetin-alfa-3-times-weekly-once-weekly","indication":"Anemia associated with chronic kidney disease","status":"phase_3"},{"name":"Epoetin alfa once every two weeks","genericName":"Epoetin alfa once every two weeks","slug":"epoetin-alfa-once-every-two-weeks","indication":"Anemia associated with chronic kidney disease","status":"phase_3"},{"name":"Epoetin alfa once weekly","genericName":"Epoetin alfa once weekly","slug":"epoetin-alfa-once-weekly","indication":"Anemia associated with chronic kidney disease","status":"phase_3"},{"name":"Gemcitabine with R115777","genericName":"Gemcitabine with R115777","slug":"gemcitabine-with-r115777","indication":"Pancreatic cancer","status":"phase_3"},{"name":"JNJ-90301900 (NBTXR3)","genericName":"JNJ-90301900 (NBTXR3)","slug":"jnj-90301900-nbtxr3","indication":"Locally advanced squamous cell carcinoma of the head and neck (in combination with radiotherapy)","status":"phase_3"},{"name":"RYBREVANT","genericName":"AMIVANTAMAB-VMJW","slug":"amivantamab-vmjw","indication":"Advanced or metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations","status":"marketed"},{"name":"TALVEY","genericName":"TALQUETAMAB-TGVS","slug":"talquetamab-tgvs","indication":"Relapsed or refractory multiple myeloma","status":"marketed"},{"name":"TECVAYLI","genericName":"TECLISTAMAB-CQYV","slug":"teclistamab-cqyv","indication":"Relapsed or Refractory Multiple Myeloma (Combination Therapy)","status":"marketed"},{"name":"Tipifarnib;Zarnestra; R115777","genericName":"Tipifarnib;Zarnestra; R115777","slug":"tipifarnib-zarnestra-r115777","indication":"Acute myeloid leukemia","status":"phase_3"},{"name":"Yondelis","genericName":"TRABECTEDIN","slug":"trabectedin","indication":"Leiomyosarcoma","status":"marketed"},{"name":"Yondelis","genericName":"Yondelis","slug":"yondelis","indication":"Leiomyosarcoma","status":"marketed"}]},{"name":"Immunology","slug":"immunology","revenue":13100000000,"percentOfTotal":31.2,"drugCount":12,"colorKey":"immunology","drugs":[{"name":"Stelara","genericName":"ustekinumab","slug":"ustekinumab","indication":"Crohn's disease","status":"marketed","revenue":9500000000},{"name":"Tremfya","genericName":"GUSELKUMAB","slug":"guselkumab","indication":"Palmoplantar pustulosis","status":"marketed","revenue":3600000000},{"name":"Remicade","genericName":"Infliximab-Dyyb","slug":"inflectra","indication":"Ankylosing spondylitis","status":"marketed"},{"name":"Remicade","genericName":"infliximab","slug":"infliximab","indication":"Ankylosing spondylitis","status":"discontinued"},{"name":"Colloidal Oatmeal Cream","genericName":"Colloidal Oatmeal Cream","slug":"colloidal-oatmeal-cream","indication":"Dry skin and itching","status":"marketed"},{"name":"Commercial ibuprofen","genericName":"Commercial ibuprofen","slug":"commercial-ibuprofen","indication":"Mild to moderate pain","status":"phase_3"},{"name":"Commercial naproxen sodium tablet","genericName":"Commercial naproxen sodium tablet","slug":"commercial-naproxen-sodium-tablet","indication":"Mild to moderate pain","status":"phase_3"},{"name":"Intelence","genericName":"ETRAVIRINE","slug":"etravirine","indication":"Human immunodeficiency virus infection","status":"marketed"},{"name":"Pain Relief Ointment","genericName":"Pain Relief Ointment","slug":"pain-relief-ointment","indication":"Localized musculoskeletal pain and minor aches","status":"marketed"},{"name":"Prezista","genericName":"DARUNAVIR","slug":"darunavir","indication":"Human immunodeficiency virus infection","status":"marketed"},{"name":"Test naproxen sodium tablet","genericName":"Test naproxen sodium tablet","slug":"test-naproxen-sodium-tablet","indication":"Relief of pain, inflammation, and fever","status":"phase_3"},{"name":"Ultram","genericName":"tramadol","slug":"tramadol","indication":"Chronic pain","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":4600000000,"percentOfTotal":11,"drugCount":19,"colorKey":"cardiovascular","drugs":[{"name":"Invega Sustenna","genericName":"PALIPERIDONE PALMITATE","slug":"paliperidone-palmitate","indication":"Schizophrenia","status":"marketed","revenue":3800000000},{"name":"Spravato","genericName":"ESKETAMINE","slug":"esketamine","indication":"Depressive disorder","status":"marketed","revenue":800000000},{"name":"Risperdal","genericName":"risperidone","slug":"risperidone","indication":"Bipolar affective disorder, current episode manic","status":"marketed"},{"name":"Risperidone low dose","genericName":"Risperidone low dose","slug":"risperidone-low-dose","indication":"Schizophrenia","status":"marketed"},{"name":"14C-paliperidone","genericName":"14C-paliperidone","slug":"14c-paliperidone","indication":"Schizophrenia","status":"phase_1"},{"name":"Abilify","genericName":"Abilify","slug":"abilify","indication":"Agitation associated with Bipolar Mania","status":"marketed"},{"name":"Axert","genericName":"ALMOTRIPTAN","slug":"almotriptan","indication":"Migraine","status":"marketed"},{"name":"ER OROS Paliperidone","genericName":"ER OROS Paliperidone","slug":"er-oros-paliperidone","indication":"Schizophrenia","status":"phase_3"},{"name":"Extended-release galantamine hydrobromide","genericName":"Extended-release galantamine hydrobromide","slug":"extended-release-galantamine-hydrobromide","indication":"Mild to moderate Alzheimer's disease","status":"phase_3"},{"name":"Haldol","genericName":"HALOPERIDOL DECANOATE","slug":"haloperidol-decanoate","indication":"Chronic schizophrenia","status":"marketed"},{"name":"Paliperidone ER OROS","genericName":"Paliperidone ER OROS","slug":"paliperidone-er-oros","indication":"Schizophrenia","status":"phase_3"},{"name":"Razadyne","genericName":"GALANTAMINE","slug":"galantamine","indication":"Mild to moderate dementia of the Alzheimer's type","status":"marketed"},{"name":"Risperidone high dose","genericName":"Risperidone high dose","slug":"risperidone-high-dose","indication":"Schizophrenia","status":"marketed"},{"name":"Risperidone, oral tablets","genericName":"Risperidone, oral tablets","slug":"risperidone-oral-tablets","indication":"Schizophrenia","status":"phase_3"},{"name":"Topamax","genericName":"topiramate","slug":"topiramate","indication":"Epilepsy characterized by intractable complex partial seizures","status":"marketed"},{"name":"Topiramate monotherapy","genericName":"Topiramate monotherapy","slug":"topiramate-monotherapy","indication":"Epilepsy / seizure disorders (monotherapy and adjunctive therapy)","status":"marketed"},{"name":"Topiramate; Carbamazepine; Valproate","genericName":"Topiramate; Carbamazepine; Valproate","slug":"topiramate-carbamazepine-valproate","indication":"Partial onset seizures","status":"phase_3"},{"name":"topiramate, phenytoin","genericName":"topiramate, phenytoin","slug":"topiramate-phenytoin","indication":"Seizure prevention in patients with epilepsy","status":"phase_3"},{"name":"topiramate, propranolol","genericName":"topiramate, propranolol","slug":"topiramate-propranolol","indication":"Seizure prevention in patients with epilepsy","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":1100000000,"percentOfTotal":2.6,"drugCount":40,"colorKey":"neuroscience","drugs":[{"name":"Carvykti","genericName":"ciltacabtagene autoleucel","slug":"ciltacabtagene-autoleucel","indication":"Other","status":"marketed","revenue":1100000000},{"name":"Benadryl","genericName":"diphenhydramine","slug":"diphenhydramine","indication":"Allergic conjunctivitis","status":"marketed"},{"name":"Placebo Caplet","genericName":"Placebo Caplet","slug":"placebo-caplet","indication":"Clinical trial control comparator (non-therapeutic use)","status":"phase_3"},{"name":"Synestrol","genericName":"DIENESTROL","slug":"dienestrol","indication":"Atrophic vaginitis","status":"marketed"},{"name":"acetaminophen extended release caplets","genericName":"acetaminophen extended release caplets","slug":"acetaminophen-extended-release-caplets","indication":"Other","status":"marketed"},{"name":"14C-JNJ-39823277","genericName":"14C-JNJ-39823277","slug":"14c-jnj-39823277","indication":"Other","status":"phase_1"},{"name":"14C-JNJ26489112","genericName":"14C-JNJ26489112","slug":"14c-jnj26489112","indication":"Other","status":"phase_1"},{"name":"Becaplermin users","genericName":"Becaplermin users","slug":"becaplermin-users","indication":"Ulcerative wounds","status":"phase_2"},{"name":"Colgate® Regular Cavity Protection","genericName":"Colgate® Regular Cavity Protection","slug":"colgate-regular-cavity-protection","indication":"Other","status":"marketed"},{"name":"Current Domperidone","genericName":"Current Domperidone","slug":"current-domperidone","indication":"Gastroparesis","status":"phase_2"},{"name":"Espumisan","genericName":"Espumisan","slug":"espumisan","indication":"Other","status":"phase_3"},{"name":"Fentanyl transdermal therapeutic system","genericName":"Fentanyl transdermal therapeutic system","slug":"fentanyl-transdermal-therapeutic-system","indication":"Other","status":"marketed"},{"name":"Haldol","genericName":"haloperidol","slug":"haloperidol","indication":"Management of Psychotic Disorders","status":"marketed"},{"name":"Imaavy","genericName":"NIPOCALIMAB","slug":"nipocalimab","indication":"Generalized Myasthenia Gravis (gMG)","status":"marketed"},{"name":"Imonogas","genericName":"Imonogas","slug":"imonogas","indication":"Other","status":"phase_3"},{"name":"Investigational lipid eye drops","genericName":"Investigational lipid eye drops","slug":"investigational-lipid-eye-drops","indication":"Other","status":"phase_1"},{"name":"JNJ 40929837","genericName":"JNJ 40929837","slug":"jnj-40929837","indication":"Other","status":"phase_2"},{"name":"LISTERINE COOL MINT Antiseptic Mouthwash","genericName":"LISTERINE COOL MINT Antiseptic Mouthwash","slug":"listerine-cool-mint-antiseptic-mouthwash","indication":"Reduction of plaque and gingivitis","status":"marketed"},{"name":"Listerine Clinical Solutions Teeth Strength","genericName":"Listerine Clinical Solutions Teeth Strength","slug":"listerine-clinical-solutions-teeth-strength","indication":"Enamel strengthening and tooth sensitivity reduction","status":"marketed"},{"name":"Listerine Experimental Mouthwash","genericName":"Listerine Experimental Mouthwash","slug":"listerine-experimental-mouthwash","indication":"Reduction of plaque and gingivitis","status":"marketed"},{"name":"Listerine Total Care Zero","genericName":"Listerine Total Care Zero","slug":"listerine-total-care-zero","indication":"Reduction of plaque and gingivitis","status":"marketed"},{"name":"Micronor","genericName":"norethisterone","slug":"norethisterone","indication":"Heavy menstrual bleeding associated with uterine leiomyomas","status":"marketed"},{"name":"Motilium","genericName":"domperidone","slug":"domperidone","indication":"Nausea and vomiting","status":"marketed"},{"name":"Other atypical antipsychotic drugs","genericName":"Other atypical antipsychotic drugs","slug":"other-atypical-antipsychotic-drugs","indication":"Other","status":"marketed"},{"name":"Paliperidone ER","genericName":"Paliperidone ER","slug":"paliperidone-er","indication":"Other","status":"marketed"},{"name":"Pancrease MT 10.5, or MT 21","genericName":"Pancrease MT 10.5, or MT 21","slug":"pancrease-mt-10-5-or-mt-21","indication":"Exocrine pancreatic insufficiency","status":"phase_3"},{"name":"Pentosan polysulfate sodium 100 mg","genericName":"Pentosan polysulfate sodium 100 mg","slug":"pentosan-polysulfate-sodium-100-mg","indication":"Other","status":"marketed"},{"name":"Placebo Liquid-filled capsule","genericName":"Placebo Liquid-filled capsule","slug":"placebo-liquid-filled-capsule","indication":"Treatment of various conditions in clinical trials as a control","status":"phase_3"},{"name":"Placebo for Pancrease MT 10.5 or MT 21","genericName":"Placebo for Pancrease MT 10.5 or MT 21","slug":"placebo-for-pancrease-mt-10-5-or-mt-21","indication":"Treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions","status":"phase_3"},{"name":"Risperidone immediate-release","genericName":"Risperidone immediate-release","slug":"risperidone-immediate-release","indication":"Other","status":"marketed"},{"name":"Topiramate add-on therapy","genericName":"Topiramate add-on therapy","slug":"topiramate-add-on-therapy","indication":"Other","status":"marketed"},{"name":"ULTRAM ER","genericName":"ULTRAM ER","slug":"ultram-er","indication":"Other","status":"marketed"},{"name":"acetaminophen Caplet","genericName":"acetaminophen Caplet","slug":"acetaminophen-caplet","indication":"Other","status":"marketed"},{"name":"doripenum","genericName":"doripenum","slug":"doripenum","indication":"Other","status":"phase_3"},{"name":"ibuprofen Liquid-filled capsule","genericName":"ibuprofen Liquid-filled capsule","slug":"ibuprofen-liquid-filled-capsule","indication":"Other","status":"marketed"},{"name":"loperamide-simethicone","genericName":"loperamide-simethicone","slug":"loperamide-simethicone","indication":"Acute diarrhea with associated gas, bloating, and abdominal discomfort","status":"marketed"},{"name":"norelgestromin + ethinyl estradiol","genericName":"norelgestromin + ethinyl estradiol","slug":"norelgestromin-ethinyl-estradiol","indication":"Contraception (prevention of pregnancy)","status":"marketed"},{"name":"norelgestromin + ethinyl estradiol; mercilon","genericName":"norelgestromin + ethinyl estradiol; mercilon","slug":"norelgestromin-ethinyl-estradiol-mercilon","indication":"Contraception","status":"phase_3"},{"name":"norelgestromin + ethinyl estradiol; triphasil.","genericName":"norelgestromin + ethinyl estradiol; triphasil.","slug":"norelgestromin-ethinyl-estradiol-triphasil","indication":"Contraception","status":"phase_3"},{"name":"risperidone, quetiapine","genericName":"risperidone, quetiapine","slug":"risperidone-quetiapine","indication":"Other","status":"marketed"}]},{"name":"Metabolic","slug":"metabolic","revenue":800000000,"percentOfTotal":1.9,"drugCount":4,"colorKey":"infectious","drugs":[{"name":"Invokana","genericName":"CANAGLIFLOZIN","slug":"canagliflozin","indication":"Chronic kidney disease (CKD) associated with type 2 diabetes (T2D)","status":"marketed","revenue":800000000},{"name":"CG5503","genericName":"CG5503","slug":"cg5503","indication":"Type 2 diabetes","status":"phase_3"},{"name":"Canagliflozin (JNJ-28431754)","genericName":"Canagliflozin (JNJ-28431754)","slug":"canagliflozin-jnj-28431754","indication":"Type 2 diabetes mellitus","status":"phase_3"},{"name":"JNJ16269110","genericName":"JNJ16269110","slug":"jnj16269110","indication":"Type 2 diabetes","status":"phase_2"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":400000000,"percentOfTotal":1,"drugCount":10,"colorKey":"respiratory","drugs":[{"name":"Sirturo","genericName":"bedaquiline","slug":"bedaquiline","indication":"Drug resistant tuberculosis","status":"marketed","revenue":400000000},{"name":"Antiseptic Wash","genericName":"Antiseptic Wash","slug":"antiseptic-wash","indication":"Skin antisepsis and cleansing","status":"marketed"},{"name":"Meclan","genericName":"MECLOCYCLINE","slug":"meclocycline","indication":"Acne vulgaris","status":"marketed"},{"name":"Monistat","genericName":"miconazole","slug":"miconazole","indication":"Candidal vulvovaginitis","status":"marketed"},{"name":"Nizoral","genericName":"ketoconazole","slug":"ketoconazole","indication":"Blastomycosis","status":"marketed"},{"name":"Sulfabenzid","genericName":"SULFABENZAMIDE","slug":"sulfabenzamide","indication":"Gardnerella Vaginalis Bacterial Vaginosis","status":"marketed"},{"name":"ibuprofen; pseudoephedrine HCl","genericName":"ibuprofen; pseudoephedrine HCl","slug":"ibuprofen-pseudoephedrine-hcl","indication":"Pain and fever relief associated with the common cold, flu, and upper respiratory infections with nasal congestion","status":"marketed"},{"name":"levofloxacin, azithromycin, amoxicillin/clavulanate","genericName":"levofloxacin, azithromycin, amoxicillin/clavulanate","slug":"levofloxacin-azithromycin-amoxicillin-clavulanate","indication":"Community-acquired pneumonia","status":"phase_3"},{"name":"levofloxacin; amoxicillin/clavulanate","genericName":"levofloxacin; amoxicillin/clavulanate","slug":"levofloxacin-amoxicillin-clavulanate","indication":"Community-acquired pneumonia","status":"phase_3"},{"name":"levofloxacin; metronidazole","genericName":"levofloxacin; metronidazole","slug":"levofloxacin-metronidazole","indication":"Mixed aerobic and anaerobic bacterial infections","status":"marketed"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":8,"colorKey":"ophthalmology","drugs":[{"name":"CG 5503;tapentadol","genericName":"CG 5503;tapentadol","slug":"cg-5503-tapentadol","indication":"Moderate to severe acute pain","status":"phase_3"},{"name":"CG5503 IR; tapentadol","genericName":"CG5503 IR; tapentadol","slug":"cg5503-ir-tapentadol","indication":"Acute pain management","status":"phase_3"},{"name":"Commercial acetaminophen","genericName":"Commercial acetaminophen","slug":"commercial-acetaminophen","indication":"Mild to moderate pain","status":"phase_3"},{"name":"Imodium","genericName":"loperamide","slug":"loperamide","indication":"Diarrhea","status":"marketed"},{"name":"Parafon Forte Dsc","genericName":"CHLORZOXAZONE","slug":"chlorzoxazone","indication":"Muscle Spasm with Pain","status":"marketed"},{"name":"Tapentadol ER (CG5503)","genericName":"Tapentadol ER (CG5503)","slug":"tapentadol-er-cg5503","indication":"Chronic pain","status":"phase_3"},{"name":"Test acetaminophen","genericName":"Test acetaminophen","slug":"test-acetaminophen","indication":"Relief of mild to moderate pain","status":"phase_3"},{"name":"Tramadol /acetaminophen","genericName":"Tramadol /acetaminophen","slug":"tramadol-acetaminophen","indication":"Moderate pain management","status":"marketed"}]},{"name":"Ophthalmology","slug":"ophthalmology","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"metabolic","drugs":[{"name":"Blink® Tears eye drops","genericName":"Blink® Tears eye drops","slug":"blink-tears-eye-drops","indication":"Relief of dryness and irritation associated with dry eye syndrome","status":"phase_2"},{"name":"F# 13418-148 Eye Drops","genericName":"F# 13418-148 Eye Drops","slug":"f-13418-148-eye-drops","indication":"Dry eye disease (presumed, based on eye drop formulation)","status":"phase_3"},{"name":"F# PF-004390 Eye Drops","genericName":"F# PF-004390 Eye Drops","slug":"f-pf-004390-eye-drops","indication":"Dry eye disease (ocular surface pain)","status":"phase_3"},{"name":"F#13418-158 Eye Drops","genericName":"F#13418-158 Eye Drops","slug":"f-13418-158-eye-drops","indication":"Dry eye disease (presumed, based on formulation type)","status":"phase_3"}]},{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"dermatology","drugs":[{"name":"GRIFULVIN V","genericName":"GRISEOFULVIN, MICROCRYSTALLINE","slug":"griseofulvin-microcrystalline","indication":"Onychomycosis due to dermatophyte","status":"marketed"},{"name":"Grifulvin V","genericName":"GRISEOFULVIN","slug":"griseofulvin","indication":"Onychomycosis due to dermatophyte","status":"marketed"},{"name":"Vehicle Topical Foam","genericName":"Vehicle Topical Foam","slug":"vehicle-topical-foam","indication":"Topical delivery vehicle for dermatological agents","status":"phase_3"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"rare","drugs":[{"name":"Xarelto","genericName":"rivaroxaban","slug":"rivaroxaban","indication":"Deep venous thrombosis","status":"marketed"},{"name":"Reopro","genericName":"ABCIXIMAB","slug":"abciximab","indication":"Percutaneous coronary intervention","status":"marketed"}]}],"pipeline":[{"name":"Darzalex","genericName":"daratumumab","slug":"daratumumab","phase":"marketed","mechanism":"Daratumumab binds CD38 on tumor cells, inducing apoptosis and immune-mediated lysis via CDC, ADCC, and ADCP.","indications":["Multiple myeloma","Systemic AL amyloidosis"],"catalyst":""},{"name":"Stelara","genericName":"ustekinumab","slug":"ustekinumab","phase":"marketed","mechanism":"Ustekinumab binds to the p40 subunit of IL-12 and IL-23, disrupting their signaling and reducing inflammation.","indications":["Crohn's disease","Plaque psoriasis","Psoriasis","Psoriasis with arthropathy","Ulcerative colitis"],"catalyst":""},{"name":"Remicade","genericName":"INFLIXIMAB","slug":"chembl-chembl1201581","phase":"marketed","mechanism":"Remicade works by binding to and neutralizing tumor necrosis factor, a protein that promotes inflammation and tissue damage.","indications":["Ankylosing spondylitis","Behcet's disease","Crohn's disease","Erythrodermic psoriasis","Plaque psoriasis"],"catalyst":""},{"name":"Invega Sustenna","genericName":"PALIPERIDONE PALMITATE","slug":"paliperidone-palmitate","phase":"marketed","mechanism":"Invega Sustenna works by blocking a specific channel in the brain that helps regulate electrical activity.","indications":["Schizophrenia"],"catalyst":""},{"name":"Tremfya","genericName":"GUSELKUMAB","slug":"guselkumab","phase":"marketed","mechanism":"Guselkumab binds to IL-23's p19 subunit, blocking its interaction with the IL-23 receptor and inhibiting proinflammatory cytokine release.","indications":["Palmoplantar pustulosis","Plaque psoriasis"],"catalyst":""},{"name":"Erleada","genericName":"apalutamide","slug":"apalutamide","phase":"marketed","mechanism":"Erleada blocks the androgen receptor, a protein that helps cancer cells grow.","indications":["Castration-resistant prostate cancer","Malignant tumor of prostate","Metastasis from malignant tumor of prostate"],"catalyst":""},{"name":"Zytiga","genericName":"abiraterone-acetate","slug":"abiraterone-acetate","phase":"marketed","mechanism":"Zytiga blocks the production of male hormones that fuel prostate cancer growth.","indications":["Malignant tumor of prostate","Metastatic castration-resistant prostate cancer"],"catalyst":""},{"name":"Carvykti","genericName":"ciltacabtagene autoleucel","slug":"ciltacabtagene-autoleucel","phase":"marketed","mechanism":"","indications":[],"catalyst":""},{"name":"Invokana","genericName":"CANAGLIFLOZIN","slug":"canagliflozin","phase":"marketed","mechanism":"Invokana works by blocking the SGLT2 protein in the kidneys to reduce glucose reabsorption.","indications":["Chronic kidney disease (CKD) associated with type 2 diabetes (T2D)","Diabetes mellitus type 2"],"catalyst":""},{"name":"Rybrevant","genericName":"AMIVANTAMAB","slug":"amivantamab","phase":"marketed","mechanism":"Amivantamab-vmjw targets EGFR and MET, disrupting their signaling and enhancing immune cell-mediated destruction of tumor cells.","indications":["Advanced or metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations"],"catalyst":""},{"name":"Spravato","genericName":"ESKETAMINE","slug":"esketamine","phase":"marketed","mechanism":"Spravato works by blocking the action of glutamate, a neurotransmitter involved in mood regulation.","indications":["Depressive disorder"],"catalyst":""},{"name":"Sirturo","genericName":"bedaquiline","slug":"bedaquiline","phase":"marketed","mechanism":"Sirturo works by blocking the potassium voltage-gated channel subfamily H member 2, which is essential for the survival of Mycobacterium tuberculosis bacteria.","indications":["Drug resistant tuberculosis","Pulmonary tuberculosis"],"catalyst":""},{"name":"Bcmaxcd3","genericName":"TECLISTAMAB","slug":"teclistamab","phase":"marketed","mechanism":"Teclistamab-cqyv activates T-cells by binding to CD3 and BCMA, leading to the lysis of multiple myeloma cells.","indications":["Relapsed or Refractory Multiple Myeloma (Combination Therapy)","Relapsed or Refractory Multiple Myeloma (Monotherapy)"],"catalyst":""},{"name":"Talvey","genericName":"TALQUETAMAB","slug":"talquetamab","phase":"marketed","mechanism":"Talquetamab binds to the T-cell surface glycoprotein CD3, triggering a response that kills cancer cells.","indications":["Relapsed or refractory multiple myeloma"],"catalyst":""},{"name":"Balversa","genericName":"ERDAFITINIB","slug":"erdafitinib","phase":"marketed","mechanism":"Balversa works by blocking the fibroblast growth factor receptor 1, a protein that helps cancer cells grow and spread.","indications":["Locally advanced or metastatic urothelial carcinoma"],"catalyst":""},{"name":"Remicade","genericName":"Infliximab-Dyyb","slug":"inflectra","phase":"marketed","mechanism":"Infliximab-dyyb neutralizes TNFα by binding with high affinity to soluble and transmembrane forms, inhibiting receptor binding.","indications":["Ankylosing spondylitis","Behcet's disease","Crohn's disease","Erythrodermic psoriasis","Plaque psoriasis"],"catalyst":""},{"name":"Remicade","genericName":"infliximab","slug":"infliximab","phase":"discontinued","mechanism":"Infliximab binds to TNFα, blocking its interaction with receptors, reducing inflammation and immune responses.","indications":["Ankylosing spondylitis","Behcet's disease","Crohn's disease","Erythrodermic psoriasis","Plaque psoriasis"],"catalyst":""},{"name":"Xarelto","genericName":"rivaroxaban","slug":"rivaroxaban","phase":"marketed","mechanism":"Selective FXa inhibitor that decreases thrombin generation without requiring cofactors.","indications":["Deep venous thrombosis","Nonvalvular atrial fibrillation","Peripheral arterial disease","Prevention of atherothrombotic events after an acute coronary syndrome","Prevention of atherothrombotic events at high risk of ischaemic events"],"catalyst":""},{"name":"Benadryl","genericName":"diphenhydramine","slug":"diphenhydramine","phase":"marketed","mechanism":"Histamine H4 receptor, Solute carrier family 22 member 2, 5-hydroxytryptamine receptor 2A","indications":["Allergic conjunctivitis","Insomnia","Seasonal allergic rhinitis","Vasomotor rhinitis"],"catalyst":""},{"name":"Placebo Caplet","genericName":"Placebo Caplet","slug":"placebo-caplet","phase":"phase_3","mechanism":"A placebo caplet contains no active pharmaceutical ingredient and produces therapeutic effects primarily through the placebo effect.","indications":["Clinical trial control comparator (non-therapeutic use)"],"catalyst":""},{"name":"Risperdal","genericName":"risperidone","slug":"risperidone","phase":"marketed","mechanism":"Atypical antipsychotic that antagonizes dopamine D2 and serotonin 5-HT2A receptors for schizophrenia and bipolar disorder.","indications":["Bipolar affective disorder, current episode manic","Bipolar disorder in remission","Infantile autism","Mixed bipolar I disorder","Schizophrenia"],"catalyst":""},{"name":"Risperidone low dose","genericName":"Risperidone low dose","slug":"risperidone-low-dose","phase":"marketed","mechanism":"Risperidone blocks dopamine D2 and serotonin 5-HT2A receptors in the brain to reduce psychotic symptoms and stabilize mood.","indications":["Schizophrenia","Bipolar I disorder (acute mania and maintenance)","Irritability associated with autism spectrum disorder","Aggression and behavioral disturbances in dementia"],"catalyst":""},{"name":"Synestrol","genericName":"DIENESTROL","slug":"dienestrol","phase":"marketed","mechanism":"Estrogen receptor","indications":["Atrophic vaginitis","Atrophic vulva","Dyspareunia"],"catalyst":""},{"name":"acetaminophen extended release caplets","genericName":"acetaminophen extended release caplets","slug":"acetaminophen-extended-release-caplets","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"14C-JNJ-39823277","genericName":"14C-JNJ-39823277","slug":"14c-jnj-39823277","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"14C-JNJ26489112","genericName":"14C-JNJ26489112","slug":"14c-jnj26489112","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"14C-paliperidone","genericName":"14C-paliperidone","slug":"14c-paliperidone","phase":"phase_1","mechanism":"Dopamine D2 receptor antagonist","indications":["Schizophrenia"],"catalyst":""},{"name":"Abilify","genericName":"Abilify","slug":"abilify","phase":"marketed","mechanism":"5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A, 5-hydroxytryptamine receptor 6","indications":["Agitation associated with Bipolar Mania","Agitation associated with Schizophrenia","Bipolar affective disorder, current episode manic","Bipolar disorder in remission","Depression Treatment Adjunct"],"catalyst":""},{"name":"Abiraterone Acetate","genericName":"ABIRATERONE","slug":"chembl-chembl254328","phase":"marketed","mechanism":"Abiraterone Acetate blocks the production of androgens, which are hormones that prostate cancer cells need to grow.","indications":["Metastatic castration-resistant prostate cancer (CRPC)","Metastatic high-risk castration-sensitive prostate cancer (CSPC)"],"catalyst":""},{"name":"Antiseptic Wash","genericName":"Antiseptic Wash","slug":"antiseptic-wash","phase":"marketed","mechanism":"Antiseptic wash kills or inhibits microorganisms on skin through chemical antimicrobial agents.","indications":["Skin antisepsis and cleansing","Prevention of minor skin infections","Preoperative skin preparation"],"catalyst":""},{"name":"Axert","genericName":"ALMOTRIPTAN","slug":"almotriptan","phase":"marketed","mechanism":"Axert works by binding to serotonin receptors in the brain to relieve migraine pain.","indications":["Migraine"],"catalyst":""},{"name":"Becaplermin users","genericName":"Becaplermin users","slug":"becaplermin-users","phase":"phase_2","mechanism":"Stimulates wound healing by promoting the proliferation and differentiation of keratinocytes and fibroblasts","indications":["Ulcerative wounds"],"catalyst":""},{"name":"Blink® Tears eye drops","genericName":"Blink® Tears eye drops","slug":"blink-tears-eye-drops","phase":"phase_2","mechanism":"Blink Tears eye drops lubricate the eyes to relieve dryness and irritation.","indications":["Relief of dryness and irritation associated with dry eye syndrome"],"catalyst":""},{"name":"CG 5503;tapentadol","genericName":"CG 5503;tapentadol","slug":"cg-5503-tapentadol","phase":"phase_3","mechanism":"Tapentadol is a mu-opioid receptor agonist and norepinephrine reuptake inhibitor that provides analgesia through dual mechanisms.","indications":["Moderate to severe acute pain","Moderate to severe chronic pain"],"catalyst":""},{"name":"CG5503","genericName":"CG5503","slug":"cg5503","phase":"phase_3","mechanism":"CG5503 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"CG5503 IR; tapentadol","genericName":"CG5503 IR; tapentadol","slug":"cg5503-ir-tapentadol","phase":"phase_3","mechanism":"Tapentadol is a mu-opioid receptor agonist and norepinephrine reuptake inhibitor that provides analgesia through dual mechanisms of action.","indications":["Acute pain management","Moderate to severe pain"],"catalyst":""},{"name":"Canagliflozin (JNJ-28431754)","genericName":"Canagliflozin (JNJ-28431754)","slug":"canagliflozin-jnj-28431754","phase":"phase_3","mechanism":"Canagliflozin inhibits sodium-glucose cotransporter 2 (SGLT2) in the kidney, reducing reabsorption of glucose and promoting urinary glucose excretion to lower blood glucose levels.","indications":["Type 2 diabetes mellitus"],"catalyst":""},{"name":"Colgate® Regular Cavity Protection","genericName":"Colgate® Regular Cavity Protection","slug":"colgate-regular-cavity-protection","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Colloidal Oatmeal Cream","genericName":"Colloidal Oatmeal Cream","slug":"colloidal-oatmeal-cream","phase":"marketed","mechanism":"Colloidal oatmeal forms a protective barrier on the skin and provides anti-inflammatory and emollient properties to soothe irritated skin.","indications":["Dry skin and itching","Eczema and atopic dermatitis","Psoriasis","General skin irritation and inflammation"],"catalyst":""},{"name":"Commercial acetaminophen","genericName":"Commercial acetaminophen","slug":"commercial-acetaminophen","phase":"phase_3","mechanism":"Acetaminophen reduces pain and fever by inhibiting prostaglandin synthesis in the central nervous system.","indications":["Mild to moderate pain","Fever reduction"],"catalyst":""},{"name":"Commercial ibuprofen","genericName":"Commercial ibuprofen","slug":"commercial-ibuprofen","phase":"phase_3","mechanism":"Ibuprofen inhibits cyclooxygenase (COX) enzymes to reduce the production of prostaglandins, thereby decreasing inflammation, pain, and fever.","indications":["Mild to moderate pain","Fever reduction","Inflammation associated with headache, muscular aches, backache, minor arthritis pain, menstrual cramps, and common cold"],"catalyst":""},{"name":"Commercial naproxen sodium tablet","genericName":"Commercial naproxen sodium tablet","slug":"commercial-naproxen-sodium-tablet","phase":"phase_3","mechanism":"Naproxen sodium inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation, pain, and fever.","indications":["Mild to moderate pain","Fever","Inflammation associated with conditions such as headache, muscular aches, backache, minor arthritis pain, menstrual cramps, and the common cold"],"catalyst":""},{"name":"Current Domperidone","genericName":"Current Domperidone","slug":"current-domperidone","phase":"phase_2","mechanism":"Current Domperidone acts as a dopamine D2 receptor antagonist.","indications":["Gastroparesis"],"catalyst":""},{"name":"Duragesic","genericName":"fentanyl","slug":"fentanyl","phase":"marketed","mechanism":"Synthetic opioid 50-100x more potent than morphine that binds mu-opioid receptors, providing potent analgesia and anesthesia.","indications":["Acute postoperative pain","Breakthrough Pain in Opioid Tolerant Patients","Breakthrough cancer pain","Chronic Pain with Opioid Tolerance","General anesthesia"],"catalyst":""},{"name":"ER OROS Paliperidone","genericName":"ER OROS Paliperidone","slug":"er-oros-paliperidone","phase":"phase_3","mechanism":"Paliperidone is an atypical antipsychotic that blocks dopamine D2 and serotonin 5-HT2A receptors in the brain.","indications":["Schizophrenia","Schizoaffective disorder","Bipolar I disorder (acute mania)"],"catalyst":""},{"name":"Epoetin alfa 3 times weekly /once weekly","genericName":"Epoetin alfa 3 times weekly /once weekly","slug":"epoetin-alfa-3-times-weekly-once-weekly","phase":"phase_3","mechanism":"Epoetin alfa is a recombinant erythropoietin that stimulates red blood cell production by binding to erythropoietin receptors on bone marrow progenitor cells.","indications":["Anemia associated with chronic kidney disease","Anemia in cancer patients receiving chemotherapy","Anemia in patients with HIV infection on antiretroviral therapy"],"catalyst":""},{"name":"Epoetin alfa once every two weeks","genericName":"Epoetin alfa once every two weeks","slug":"epoetin-alfa-once-every-two-weeks","phase":"phase_3","mechanism":"Epoetin alfa is a recombinant erythropoietin that stimulates red blood cell production by binding to erythropoietin receptors on bone marrow progenitor cells.","indications":["Anemia associated with chronic kidney disease","Anemia in patients with cancer receiving chemotherapy","Anemia in patients undergoing elective surgery"],"catalyst":""},{"name":"Epoetin alfa once weekly","genericName":"Epoetin alfa once weekly","slug":"epoetin-alfa-once-weekly","phase":"phase_3","mechanism":"Epoetin alfa is a recombinant erythropoietin that stimulates red blood cell production by binding to erythropoietin receptors on bone marrow progenitor cells.","indications":["Anemia associated with chronic kidney disease","Anemia in patients with cancer receiving chemotherapy","Anemia in patients undergoing elective surgery"],"catalyst":""},{"name":"Espumisan","genericName":"Espumisan","slug":"espumisan","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Extended-release galantamine hydrobromide","genericName":"Extended-release galantamine hydrobromide","slug":"extended-release-galantamine-hydrobromide","phase":"phase_3","mechanism":"Galantamine is a cholinesterase inhibitor that increases acetylcholine levels in the brain by blocking its breakdown, and also acts as an allosteric modulator of nicotinic receptors.","indications":["Mild to moderate Alzheimer's disease"],"catalyst":""},{"name":"F# 13418-148 Eye Drops","genericName":"F# 13418-148 Eye Drops","slug":"f-13418-148-eye-drops","phase":"phase_3","mechanism":"F# 13418-148 is an ophthalmic formulation designed to treat dry eye disease by lubricating and protecting the ocular surface.","indications":["Dry eye disease (presumed, based on eye drop formulation)"],"catalyst":""},{"name":"F# PF-004390 Eye Drops","genericName":"F# PF-004390 Eye Drops","slug":"f-pf-004390-eye-drops","phase":"phase_3","mechanism":"PF-004390 is a selective TRPM8 antagonist that blocks cold-sensing ion channels in the eye to reduce ocular pain and discomfort.","indications":["Dry eye disease (ocular surface pain)"],"catalyst":""},{"name":"F#13418-158 Eye Drops","genericName":"F#13418-158 Eye Drops","slug":"f-13418-158-eye-drops","phase":"phase_3","mechanism":"F#13418-158 is an ophthalmic formulation designed to treat dry eye disease by lubricating and protecting the ocular surface.","indications":["Dry eye disease (presumed, based on formulation type)"],"catalyst":""},{"name":"Fentanyl transdermal therapeutic system","genericName":"Fentanyl transdermal therapeutic system","slug":"fentanyl-transdermal-therapeutic-system","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"GRIFULVIN V","genericName":"GRISEOFULVIN, MICROCRYSTALLINE","slug":"griseofulvin-microcrystalline","phase":"marketed","mechanism":"Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin","indications":["Onychomycosis due to dermatophyte","Tinea barbae","Tinea capitis","Tinea corporis","Tinea cruris"],"catalyst":""},{"name":"Gemcitabine with R115777","genericName":"Gemcitabine with R115777","slug":"gemcitabine-with-r115777","phase":"phase_3","mechanism":"Gemcitabine is a nucleoside analog that inhibits DNA synthesis, while R115777 is a farnesyltransferase inhibitor that blocks Ras protein activation, together targeting cancer cell proliferation through complementary pathways.","indications":["Pancreatic cancer","Advanced solid tumors"],"catalyst":""},{"name":"Grifulvin V","genericName":"GRISEOFULVIN","slug":"griseofulvin","phase":"marketed","mechanism":"Solute carrier family 22 member 1","indications":["Onychomycosis due to dermatophyte","Tinea barbae","Tinea capitis","Tinea corporis","Tinea cruris"],"catalyst":""},{"name":"Haldol","genericName":"HALOPERIDOL DECANOATE","slug":"haloperidol-decanoate","phase":"marketed","mechanism":"D(2) dopamine receptor","indications":["Chronic schizophrenia"],"catalyst":""},{"name":"Haldol","genericName":"haloperidol","slug":"haloperidol","phase":"marketed","mechanism":"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A","indications":["Management of Psychotic Disorders","Control of Tics and Vocal Utterances in Tourette's Disorder","Severe Behavior Problems in Children","Short-term Treatment of Hyperactive Children"],"catalyst":""},{"name":"Imaavy","genericName":"NIPOCALIMAB","slug":"nipocalimab","phase":"marketed","mechanism":"Imaavy works by binding to and blocking the activity of certain immune cells that mistakenly attack healthy nerve-muscle connections in people with gMG.","indications":["Generalized Myasthenia Gravis (gMG)"],"catalyst":""},{"name":"Imodium","genericName":"loperamide","slug":"loperamide","phase":"marketed","mechanism":"Peripheral mu-opioid receptor agonist that slows intestinal motility and increases fluid absorption without crossing the blood-brain barrier.","indications":["Diarrhea","Diarrhea Secondary to Inflammatory Bowel Disease","Traveler's diarrhea"],"catalyst":""},{"name":"Imonogas","genericName":"Imonogas","slug":"imonogas","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Intelence","genericName":"ETRAVIRINE","slug":"etravirine","phase":"marketed","mechanism":"Intelence works by blocking the reverse transcriptase enzyme, which is essential for the replication of the HIV virus.","indications":["Human immunodeficiency virus infection"],"catalyst":""},{"name":"Investigational lipid eye drops","genericName":"Investigational lipid eye drops","slug":"investigational-lipid-eye-drops","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"JNJ 40929837","genericName":"JNJ 40929837","slug":"jnj-40929837","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"JNJ-90301900 (NBTXR3)","genericName":"JNJ-90301900 (NBTXR3)","slug":"jnj-90301900-nbtxr3","phase":"phase_3","mechanism":"NBTXR3 is a nanoparticle hafnium oxide that concentrates radiation dose within tumor cells, enhancing the cytotoxic effects of radiotherapy.","indications":["Locally advanced squamous cell carcinoma of the head and neck (in combination with radiotherapy)","Soft tissue sarcoma (in combination with radiotherapy)"],"catalyst":""},{"name":"JNJ16269110","genericName":"JNJ16269110","slug":"jnj16269110","phase":"phase_2","mechanism":"JNJ16269110 is a selective and potent antagonist of the human glucagon receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"LISTERINE COOL MINT Antiseptic Mouthwash","genericName":"LISTERINE COOL MINT Antiseptic Mouthwash","slug":"listerine-cool-mint-antiseptic-mouthwash","phase":"marketed","mechanism":"Listerine Cool Mint kills oral bacteria and reduces plaque formation through its essential oil and alcohol active ingredients.","indications":["Reduction of plaque and gingivitis","Bad breath control","General oral antisepsis"],"catalyst":""},{"name":"Listerine Clinical Solutions Teeth Strength","genericName":"Listerine Clinical Solutions Teeth Strength","slug":"listerine-clinical-solutions-teeth-strength","phase":"marketed","mechanism":"Listerine Clinical Solutions Teeth Strength is an oral rinse that strengthens tooth enamel and reduces sensitivity through fluoride and essential oil antimicrobial action.","indications":["Enamel strengthening and tooth sensitivity reduction","Plaque and gingivitis reduction"],"catalyst":""},{"name":"Listerine Experimental Mouthwash","genericName":"Listerine Experimental Mouthwash","slug":"listerine-experimental-mouthwash","phase":"marketed","mechanism":"Listerine Experimental Mouthwash kills oral bacteria and reduces plaque formation through its essential oil and antimicrobial active ingredients.","indications":["Reduction of plaque and gingivitis","Halitosis (bad breath) control","General oral antimicrobial activity"],"catalyst":""},{"name":"Listerine Total Care Zero","genericName":"Listerine Total Care Zero","slug":"listerine-total-care-zero","phase":"marketed","mechanism":"Listerine Total Care Zero is an antimicrobial oral rinse that kills bacteria and reduces plaque and gingivitis without alcohol.","indications":["Reduction of plaque and gingivitis","Antimicrobial oral hygiene maintenance"],"catalyst":""},{"name":"Meclan","genericName":"MECLOCYCLINE","slug":"meclocycline","phase":"marketed","mechanism":"Small molecule","indications":["Acne vulgaris","Actinomycotic infection","Acute bacterial sinusitis","Acute gonococcal cervicitis","Acute gonococcal endometritis"],"catalyst":""},{"name":"Micronor","genericName":"norethisterone","slug":"norethisterone","phase":"marketed","mechanism":"ORIAHNN combines elagolix, which suppresses LH and FSH to reduce ovarian sex hormones, with estradiol and norethindrone acetate to mitigate side effects.","indications":["Heavy menstrual bleeding associated with uterine leiomyomas"],"catalyst":""},{"name":"Monistat","genericName":"miconazole","slug":"miconazole","phase":"marketed","mechanism":"7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase, Malate dehydrogenase cytoplasmic , 5-hydroxytryptamine receptor 6","indications":["Candidal vulvovaginitis","Candidiasis of mouth","Candidiasis of skin","Deep mycosis","Diaper rash"],"catalyst":""},{"name":"Motilium","genericName":"domperidone","slug":"domperidone","phase":"marketed","mechanism":"Aldehyde oxidase, Multidrug and toxin extrusion protein 1, Multidrug and toxin extrusion protein 2","indications":["Nausea and vomiting"],"catalyst":""},{"name":"Nizoral","genericName":"ketoconazole","slug":"ketoconazole","phase":"marketed","mechanism":"Aldehyde oxidase, Cytochrome P450 21, Sodium/nucleoside cotransporter 1","indications":["Blastomycosis","Candidiasis of mouth","Candidiasis of skin","Chromoblastomycosis","Coccidioidomycosis"],"catalyst":""},{"name":"Other atypical antipsychotic drugs","genericName":"Other atypical antipsychotic drugs","slug":"other-atypical-antipsychotic-drugs","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Pain Relief Ointment","genericName":"Pain Relief Ointment","slug":"pain-relief-ointment","phase":"marketed","mechanism":"Pain Relief Ointment provides topical analgesia by delivering active ingredients through the skin to reduce localized pain and inflammation.","indications":["Localized musculoskeletal pain and minor aches","Arthritis pain relief"],"catalyst":""},{"name":"Paliperidone ER","genericName":"Paliperidone ER","slug":"paliperidone-er","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Paliperidone ER OROS","genericName":"Paliperidone ER OROS","slug":"paliperidone-er-oros","phase":"phase_3","mechanism":"Paliperidone ER OROS is an atypical antipsychotic that works by blocking dopamine receptors in the brain.","indications":["Schizophrenia","Schizoaffective disorder"],"catalyst":""},{"name":"Pancrease MT 10.5, or MT 21","genericName":"Pancrease MT 10.5, or MT 21","slug":"pancrease-mt-10-5-or-mt-21","phase":"phase_3","mechanism":"Pancrease MT is a pancreatic enzyme supplement used to treat exocrine pancreatic insufficiency.","indications":["Exocrine pancreatic insufficiency"],"catalyst":""},{"name":"Parafon Forte Dsc","genericName":"CHLORZOXAZONE","slug":"chlorzoxazone","phase":"marketed","mechanism":"Nitric oxide synthase, endothelial","indications":["Muscle Spasm with Pain","Spasticity"],"catalyst":""},{"name":"Pentosan polysulfate sodium 100 mg","genericName":"Pentosan polysulfate sodium 100 mg","slug":"pentosan-polysulfate-sodium-100-mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Placebo Liquid-filled capsule","genericName":"Placebo Liquid-filled capsule","slug":"placebo-liquid-filled-capsule","phase":"phase_3","mechanism":"This drug is a placebo, meaning it has no active therapeutic effect.","indications":["Treatment of various conditions in clinical trials as a control"],"catalyst":""},{"name":"Placebo for Pancrease MT 10.5 or MT 21","genericName":"Placebo for Pancrease MT 10.5 or MT 21","slug":"placebo-for-pancrease-mt-10-5-or-mt-21","phase":"phase_3","mechanism":"This is a placebo, meaning it has no active therapeutic effect.","indications":["Treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions"],"catalyst":""},{"name":"Prezista","genericName":"DARUNAVIR","slug":"darunavir","phase":"marketed","mechanism":"Darunavir works by blocking the protease enzyme, which is essential for the replication of the HIV virus.","indications":["Human immunodeficiency virus infection"],"catalyst":""},{"name":"RYBREVANT","genericName":"AMIVANTAMAB-VMJW","slug":"amivantamab-vmjw","phase":"marketed","mechanism":"Epidermal growth factor receptor, Hepatocyte growth factor receptor","indications":["Advanced or metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations"],"catalyst":""},{"name":"Razadyne","genericName":"GALANTAMINE","slug":"galantamine","phase":"marketed","mechanism":"Razadyne works by blocking the enzyme that breaks down acetylcholine, allowing more of this neurotransmitter to be available in the brain.","indications":["Mild to moderate dementia of the Alzheimer's type"],"catalyst":""},{"name":"Reopro","genericName":"ABCIXIMAB","slug":"abciximab","phase":"marketed","mechanism":"Integrin alpha-IIb/beta-3","indications":["Percutaneous coronary intervention"],"catalyst":""},{"name":"Risperidone high dose","genericName":"Risperidone high dose","slug":"risperidone-high-dose","phase":"marketed","mechanism":"Risperidone blocks dopamine D2 and serotonin 5-HT2A receptors in the brain to reduce psychotic symptoms and stabilize mood.","indications":["Schizophrenia","Bipolar I disorder (acute mania and maintenance)","Irritability associated with autism spectrum disorder","Treatment-resistant psychosis (at higher doses)"],"catalyst":""},{"name":"Risperidone immediate-release","genericName":"Risperidone immediate-release","slug":"risperidone-immediate-release","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Risperidone, oral tablets","genericName":"Risperidone, oral tablets","slug":"risperidone-oral-tablets","phase":"phase_3","mechanism":"Risperidone is an atypical antipsychotic that acts as a dopamine D2 receptor antagonist and serotonin 5-HT2A receptor antagonist.","indications":["Schizophrenia","Bipolar disorder"],"catalyst":""},{"name":"Sulfabenzid","genericName":"SULFABENZAMIDE","slug":"sulfabenzamide","phase":"marketed","mechanism":"Small molecule","indications":["Gardnerella Vaginalis Bacterial Vaginosis","Vulvovaginitis"],"catalyst":""},{"name":"TALVEY","genericName":"TALQUETAMAB-TGVS","slug":"talquetamab-tgvs","phase":"marketed","mechanism":"G-protein coupled receptor family C group 5 member D, T-cell surface glycoprotein CD3","indications":["Relapsed or refractory multiple myeloma"],"catalyst":""},{"name":"TECVAYLI","genericName":"TECLISTAMAB-CQYV","slug":"teclistamab-cqyv","phase":"marketed","mechanism":"Tumor necrosis factor receptor superfamily member 17, T-cell surface glycoprotein CD3","indications":["Relapsed or Refractory Multiple Myeloma (Combination Therapy)","Relapsed or Refractory Multiple Myeloma (Monotherapy)"],"catalyst":""},{"name":"Tapentadol ER (CG5503)","genericName":"Tapentadol ER (CG5503)","slug":"tapentadol-er-cg5503","phase":"phase_3","mechanism":"Tapentadol ER is a mu-opioid receptor agonist and norepinephrine reuptake inhibitor.","indications":["Chronic pain","Acute pain"],"catalyst":""},{"name":"Test acetaminophen","genericName":"Test acetaminophen","slug":"test-acetaminophen","phase":"phase_3","mechanism":"Acetaminophen works by inhibiting the production of prostaglandins, which are chemicals that cause pain and fever.","indications":["Relief of mild to moderate pain","Reduction of fever"],"catalyst":""},{"name":"Test naproxen sodium tablet","genericName":"Test naproxen sodium tablet","slug":"test-naproxen-sodium-tablet","phase":"phase_3","mechanism":"Naproxen sodium is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting the enzyme cyclooxygenase (COX), which is responsible for producing prostaglandins that cause pain and inflammation.","indications":["Relief of pain, inflammation, and fever","Treatment of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis"],"catalyst":""},{"name":"Tipifarnib;Zarnestra; R115777","genericName":"Tipifarnib;Zarnestra; R115777","slug":"tipifarnib-zarnestra-r115777","phase":"phase_3","mechanism":"Tipifarnib is a farnesyltransferase inhibitor that blocks the farnesylation of Ras proteins, which are involved in cell signaling and proliferation.","indications":["Acute myeloid leukemia","Basal cell carcinoma"],"catalyst":""},{"name":"Topamax","genericName":"topiramate","slug":"topiramate","phase":"marketed","mechanism":"Nuclear receptor subfamily 1 group I member 2, Carbonic anhydrase 1, Carbonic anhydrase 12","indications":["Epilepsy characterized by intractable complex partial seizures","Lennox-Gastaut syndrome","Migraine Prevention","Simple partial seizure","Tonic-clonic epilepsy"],"catalyst":""},{"name":"Topiramate add-on therapy","genericName":"Topiramate add-on therapy","slug":"topiramate-add-on-therapy","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Topiramate monotherapy","genericName":"Topiramate monotherapy","slug":"topiramate-monotherapy","phase":"marketed","mechanism":"Topiramate is an anticonvulsant that enhances GABA-mediated inhibition and blocks sodium channels to reduce neuronal excitability.","indications":["Epilepsy / seizure disorders (monotherapy and adjunctive therapy)","Migraine prophylaxis","Essential tremor"],"catalyst":""},{"name":"Topiramate; Carbamazepine; Valproate","genericName":"Topiramate; Carbamazepine; Valproate","slug":"topiramate-carbamazepine-valproate","phase":"phase_3","mechanism":"Topiramate is an anticonvulsant that acts as a voltage-dependent sodium channel blocker, whereas Carbamazepine is a tricyclic compound that stabilizes inactivated sodium channels, and Valproate is a fatty acid with anticonvulsant properties.","indications":["Partial onset seizures","Generalized seizures","Migraine prophylaxis"],"catalyst":""},{"name":"Tramadol /acetaminophen","genericName":"Tramadol /acetaminophen","slug":"tramadol-acetaminophen","phase":"marketed","mechanism":"Tramadol inhibits norepinephrine and serotonin reuptake while acting as a weak opioid agonist, and acetaminophen inhibits prostaglandin synthesis to provide combined analgesic and antipyretic effects.","indications":["Moderate pain management","Post-operative pain"],"catalyst":""},{"name":"ULTRAM ER","genericName":"ULTRAM ER","slug":"ultram-er","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Ultram","genericName":"tramadol","slug":"tramadol","phase":"marketed","mechanism":"Solute carrier family 22 member 1, Delta-type opioid receptor, Kappa-type opioid receptor","indications":["Chronic pain","Osteoarthritis","Pain"],"catalyst":""},{"name":"Vehicle Topical Foam","genericName":"Vehicle Topical Foam","slug":"vehicle-topical-foam","phase":"phase_3","mechanism":"Vehicle Topical Foam is an inert formulation base designed to deliver active pharmaceutical ingredients to the skin surface.","indications":["Topical delivery vehicle for dermatological agents"],"catalyst":""},{"name":"Yondelis","genericName":"TRABECTEDIN","slug":"trabectedin","phase":"marketed","mechanism":"Yondelis works by binding to DNA and causing interstrand crosslinks, thereby inhibiting cancer cell growth.","indications":["Leiomyosarcoma","Liposarcoma","Malignant tumor of ovary","Soft or Connective Tissue Sarcoma"],"catalyst":""},{"name":"Yondelis","genericName":"Yondelis","slug":"yondelis","phase":"marketed","mechanism":"Proto-oncogene tyrosine-protein kinase Src, Nuclear receptor subfamily 1 group I member 2","indications":["Leiomyosarcoma","Liposarcoma","Malignant tumor of ovary","Soft or Connective Tissue Sarcoma"],"catalyst":""},{"name":"acetaminophen Caplet","genericName":"acetaminophen Caplet","slug":"acetaminophen-caplet","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"doripenum","genericName":"doripenum","slug":"doripenum","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ibuprofen Liquid-filled capsule","genericName":"ibuprofen Liquid-filled capsule","slug":"ibuprofen-liquid-filled-capsule","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ibuprofen; pseudoephedrine HCl","genericName":"ibuprofen; pseudoephedrine HCl","slug":"ibuprofen-pseudoephedrine-hcl","phase":"marketed","mechanism":"Ibuprofen reduces pain and inflammation by inhibiting cyclooxygenase enzymes, while pseudoephedrine constricts blood vessels in the nasal passages to relieve congestion.","indications":["Pain and fever relief associated with the common cold, flu, and upper respiratory infections with nasal congestion","Temporary relief of sinus pressure and congestion"],"catalyst":""},{"name":"levofloxacin, azithromycin, amoxicillin/clavulanate","genericName":"levofloxacin, azithromycin, amoxicillin/clavulanate","slug":"levofloxacin-azithromycin-amoxicillin-clavulanate","phase":"phase_3","mechanism":"Levofloxacin, azithromycin, and amoxicillin/clavulanate inhibit bacterial growth through different mechanisms, targeting DNA gyrase, protein synthesis, and cell wall synthesis, respectively.","indications":["Community-acquired pneumonia","Acute bacterial sinusitis","Uncomplicated skin and skin structure infections"],"catalyst":""},{"name":"levofloxacin; amoxicillin/clavulanate","genericName":"levofloxacin; amoxicillin/clavulanate","slug":"levofloxacin-amoxicillin-clavulanate","phase":"phase_3","mechanism":"Levofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, while amoxicillin/clavulanate inhibits bacterial cell wall synthesis.","indications":["Community-acquired pneumonia","Skin and skin structure infections"],"catalyst":""},{"name":"levofloxacin; metronidazole","genericName":"levofloxacin; metronidazole","slug":"levofloxacin-metronidazole","phase":"marketed","mechanism":"This combination uses levofloxacin (a fluoroquinolone that inhibits bacterial DNA gyrase and topoisomerase IV) and metronidazole (a nitroimidazole that damages bacterial DNA) to provide broad-spectrum anaerobic and aerobic bacterial coverage.","indications":["Mixed aerobic and anaerobic bacterial infections","Intra-abdominal infections","Pelvic inflammatory disease","Diabetic foot infections with mixed flora"],"catalyst":""},{"name":"loperamide-simethicone","genericName":"loperamide-simethicone","slug":"loperamide-simethicone","phase":"marketed","mechanism":"Loperamide-simethicone combines an antimotility agent that slows intestinal movement with an anti-gas agent that reduces bloating and flatulence.","indications":["Acute diarrhea with associated gas, bloating, and abdominal discomfort"],"catalyst":""},{"name":"norelgestromin + ethinyl estradiol","genericName":"norelgestromin + ethinyl estradiol","slug":"norelgestromin-ethinyl-estradiol","phase":"marketed","mechanism":"Norelgestromin and ethinyl estradiol work together as a hormonal contraceptive by suppressing ovulation through inhibition of gonadotropin-releasing hormone (GnRH) and feedback inhibition of luteinizing hormone (LH) and follicle-stimulating hormone (FSH).","indications":["Contraception (prevention of pregnancy)","Regulation of menstrual cycle"],"catalyst":""},{"name":"norelgestromin + ethinyl estradiol; mercilon","genericName":"norelgestromin + ethinyl estradiol; mercilon","slug":"norelgestromin-ethinyl-estradiol-mercilon","phase":"phase_3","mechanism":"Norelgestromin and ethinyl estradiol are used to prevent pregnancy by suppressing ovulation and altering cervical mucus and the uterine lining.","indications":["Contraception"],"catalyst":""},{"name":"norelgestromin + ethinyl estradiol; triphasil.","genericName":"norelgestromin + ethinyl estradiol; triphasil.","slug":"norelgestromin-ethinyl-estradiol-triphasil","phase":"phase_3","mechanism":"Norelgestromin and ethinyl estradiol work together to prevent ovulation and thicken cervical mucus to prevent sperm from reaching the egg.","indications":["Contraception"],"catalyst":""},{"name":"risperidone, quetiapine","genericName":"risperidone, quetiapine","slug":"risperidone-quetiapine","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"topiramate, phenytoin","genericName":"topiramate, phenytoin","slug":"topiramate-phenytoin","phase":"phase_3","mechanism":"Topiramate is an anticonvulsant that works by blocking voltage-dependent sodium channels, stabilizing neuronal membranes, and reducing the release of excitatory neurotransmitters.","indications":["Seizure prevention in patients with epilepsy","Migraine prevention"],"catalyst":""},{"name":"topiramate, propranolol","genericName":"topiramate, propranolol","slug":"topiramate-propranolol","phase":"phase_3","mechanism":"Topiramate is an anticonvulsant that blocks voltage-dependent sodium channels and enhances the activity of GABA at the GABA_A receptor.","indications":["Seizure prevention in patients with epilepsy","Migraine prevention"],"catalyst":""}],"recentEvents":[{"date":"2023-02-08","type":"earnings","headline":"Johnson & Johnson Reports Fourth-Quarter and Full-Year 2022 Results","summary":"Johnson & Johnson reported fourth-quarter and full-year 2022 results, with net sales of $24.1 billion and adjusted earnings per share of $2.13.","drugName":"","sentiment":"neutral"},{"date":"2022-10-21","type":"deal","headline":"Johnson & Johnson to Acquire Abiomed for $8.1 Billion","summary":"Johnson & Johnson agreed to acquire Abiomed, a medical device company, for $8.1 billion.","drugName":"","sentiment":"positive"},{"date":"2022-08-19","type":"regulatory","headline":"FDA Approves Johnson & Johnson's Darzalex Faspro for Multiple Myeloma","summary":"The FDA approved Darzalex Faspro, a multiple myeloma treatment developed by Johnson & Johnson, for patients with multiple myeloma.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQR2MycVQ0ZF94ejBnQXcwcXg1enBjYWJZS2k2R2FVbjlRUm9PS2EzVk1CaXU5WlJOdWF5cmpvakZ6S3l5NnA3cHQ4S2JROGU1T1pIckowamxZVlFuTzQyc1dYN05pMkg2Z2FIQjRmTUdVMEtXTGhsNlEzQ0tLNTRSbWRJdWJWREJQRGNQc3JvYVowczBWNFlVWFFad2V3OHJMakhXOEN2TkZaMlBBRGF6M2RNUmxYcnBEYWg5Ug?oc=5","date":"2026-04-06","type":"deal","source":"MarketBeat","summary":"Aberdeen Group plc Buys 47,996 Shares of Johnson & Johnson $JNJ - MarketBeat","headline":"Aberdeen Group plc Buys 47,996 Shares of Johnson & Johnson $JNJ","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-04-05","type":"deal","source":"simplywall.st","summary":"Assessing Johnson & Johnson (JNJ) Valuation After Autoimmune Pipeline Advances And New R&D Partnership - simplywall.st","headline":"Assessing Johnson & Johnson (JNJ) Valuation After Autoimmune Pipeline Advances And New R&D Partnership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPUGhaMk5NMVN5VFNyOHFXQVYtMVpMNF8zTG96bWEtaEFVVi1sQWdZZnhuRTFBd3NtX1hZaDh6V1hsNTdTT3hLdUpReURST2dZM1pUZEZlNElrVk16cmNmNlJfRGdENVdZUk00Qk9QYk5qdmtZdmlxbm9ad2xON01YalVCOWluZGRzYTdOQ05zMmZROVppb1ZsVTlvNmlDNjNIdFp3Z3NVUExGSXI2MTNFYlpTYVllNG5wcVh0ZWVfTnNpXzA?oc=5","date":"2026-04-05","type":"pipeline","source":"MarketBeat","summary":"Johnson & Johnson $JNJ Stock Position Raised by Trust Co. of Vermont - MarketBeat","headline":"Johnson & Johnson $JNJ Stock Position Raised by Trust Co. of Vermont","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPMDBPREVsNnByR1hBOVRqclk1OUhkcUpwQWVjV0hNZndBTEx0ckQ5Ty1iazRkemJ5QkJITkw2OTdZZUUyR2xhNTFBME4tcExnLUpaR0NEZUhteThJaWQ3MWtoSGlKd3NSRjl0TmdiUlBVcVFhWEdIb3M2a0NPVkRYajJmeHg1bDJSeTF4ZDg0c2lRNHAyaW1JcTNfSVo?oc=5","date":"2026-04-02","type":"pipeline","source":"Yahoo Finance","summary":"Why Johnson & Johnson (JNJ) Is One of the Best Pharma Stocks to Invest in Now - Yahoo Finance","headline":"Why Johnson & Johnson (JNJ) Is One of the Best Pharma Stocks to Invest in Now","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxOamJOQVdhOVN1RkFIRWFZblFORzV4dDZ5eFVxbE5sZFF5TGkyVms0YnkyT2RRZlMyR3lrYnJBRjhPV1pMZWZRRGNsMVpkZ2UtWHJQUEpUenEtb1h6MWtaR1NwOE1aQ1Q4Wl8xWjFwZzN1OVlIRldnSXR3OGdoUkxGOXZVZC1WMjBMUERBMl90MjV1aTc0MVJkTTRDOVMzSlRtWVhCeXU4TUI5b0x5N3ppX0o1OXBsWFR3RllnQXhKVHpnYkVxcHExdmhrVTFHbzU3QmY3Wm5CNVBIT1hNQUHSAeMBQVVfeXFMUDBDZzdQTlRvMm5yUUxCNXIyWWs0SHpObEZkSDBKYzVPNXhMLWZOX2xaNFpjRkxZSk5nNllydmxMQ29TV3o3WUlmck1kcENKc0J5NTB1UGY2QTkxMDhQN1FEVFBSVHlUS1YyZVBaVXFpRV9ZMk1TMHF6X2xiX20yeVNiU01zWW9pbGVqS09uUG1zOXpoMTNyV0taOE9NWEhJb1FNeGdXOG15Z19jUlcwd3NXWHNjWERFWF9DRm40OTJ5Mm1tcEpzRXdzbHBzcDR0RFpubTB4NXY0WkZFN01JbVU2Uzg?oc=5","date":"2026-04-02","type":"pipeline","source":"simplywall.st","summary":"Is Johnson & Johnson (JNJ) Still Attractive After Strong 1-Year Share Price Performance? - simplywall.st","headline":"Is Johnson & Johnson (JNJ) Still Attractive After Strong 1-Year Share Price Performance?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOVlBCRjNoQmxDZmMyWWRsM01XZTZNbEZ4eWItUE9nWEFnbGp2TFEycmk3dUJhVVpna0VXVDBNX1dfQ3gtYVpyMkg1YU5fYi16c1U4Vnc2dzFVUlFQU0RXc2RfMEhQcWhPaksyeVhoYm5OZFZvVVR4SzJtTzFaaVVsOGZKeWNSOXNTdVJLaGpYOVcyeWQ5RldwS05LbzBTY0ZJWHBVYWo3Y1lLOXJ5d29sOEJ1WHc5NFBhNWM2OTB5QU1pU2hL?oc=5","date":"2026-03-30","type":"deal","source":"reuters.com","summary":"Royalty Pharma and J&J partner to develop autoimmune treatment - reuters.com","headline":"Royalty Pharma and J&J partner to develop autoimmune treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPN0J6bE5TZTM0dDZSNU9BYjdCYlpCcWQtQXdMRnRlaUxBT09SNmNib2lKZ3I0ZnhUSFU5TDI3UFJNVnRIVDQ3Mzk5VmV4NUNJTVk2ZjRUWWxGeGxyZ0J6cFZRVnU3a0wxY1I0amExYThvak5faXJFN2pIZ1ZDMjk3OUZxY0NWb3FGOGt5U2hyWFE5dThEaGNfdFZ2YVVvdw?oc=5","date":"2026-03-30","type":"pipeline","source":"Fierce Biotech","summary":"J&J secures $500M Royalty backing for autoimmune antibody program - Fierce Biotech","headline":"J&J secures $500M Royalty backing for autoimmune antibody program","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE4zVzc1T3o2NHpnU0dTd3hmMmNTbWh5aEYwVzZzMEplN2dTZl9Fa2JWVWh4R2ZNWjdTTUdNZ2RvU0JHRTJ3eHlyUDBDakJyM05sR2Z3YmQzMFdrYlV3M2V0V3FnUXdIYmpYc0tlNGVBSllXMFN2Y1dsRVhGbUhTdw?oc=5","date":"2026-03-25","type":"pipeline","source":"Barron's","summary":"Johnson & Johnson Exits 3 Biotechs but Keeps Stakes in These Rumored Acquisition Targets - Barron's","headline":"Johnson & Johnson Exits 3 Biotechs but Keeps Stakes in These Rumored Acquisition Targets - Barron's","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOaXJfQkNCbEdxVmxzWWNDOVN1SXdjaGFibV9nNnFrVlRlTS1PeGV4YTlMUVRoRGpZSnVhVkdCVEgxcFdieGRwVi1BbTJJMHE0azJBUXM4OTloYmIwQ29SLW5wN3FOMmpzNFlNcUt0N09oOGhMOXRudVhtci1IenU2UVVDVDJWT2NXRnVVclUxalZDVkg2WEV0ZWltNW9mZ0Q3M1VmTzNwamRCZ3VfVVE?oc=5","date":"2026-03-19","type":"pipeline","source":"Yahoo Finance","summary":"Barclays Sees Continued Strength in Johnson & Johnson (JNJ) Pharma Business - Yahoo Finance","headline":"Barclays Sees Continued Strength in Johnson & Johnson (JNJ) Pharma Business","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNd1liLTd4b1pNRFdQR05LWWtKNXlFaE0tYkN2bDVkbDA3LWd1eV9rSm5JYkNwTnZGVFpSZWx1ZzFhVjJFSDVMSEVkZ2I5d3czbjBzQXhhZjhSSWtrNkhSODVUX3pNOFRYcy1KeVlVOUlNTVV3aXVDYlpMMUxYaWJBcVRaeDg2RFZWSHRtZmg4YXRaV1BMU1d2OWhFSDh5RzdWbHRrRFVmNkhJQkVLOGt2MF8zZ3FRUQ?oc=5","date":"2026-03-18","type":"earnings","source":"BioSpace","summary":"J&J Reigns as Top Pharma by Revenue While Lilly Leapfrogs on Strong Obesity Sales - BioSpace","headline":"J&J Reigns as Top Pharma by Revenue While Lilly Leapfrogs on Strong Obesity Sales","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxNREMxVjc5dXZpVEZwWF9yZ0wwYTRXMG14N0htbEhkMHJoZ3dGZE01NFV1N2wtR082ZUZEeDVpUUlqdlIwaGlMWFh2MnZzelV5UVhEYkFxVWlHLVlDa2ZlNDdGZ180Z2YwWG9KNUVuc2gwaDZ2YmZDcWltWXBmak9xYXN1OE0wUHJMTVhuZHVFRW1Kcmhjak5EZEFMT2YyaUxWbFpPS3dHVlFZcFByS3JEVGZ2RzJvZVE4V1p3djcxQVNKV2xiTzI4OQ?oc=5","date":"2026-03-04","type":"pipeline","source":"reuters.com","summary":"Johnson & Johnson launches website for direct-to-consumer sales - reuters.com","headline":"Johnson & Johnson launches website for direct-to-consumer sales","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxPZVZHam9IbUVYZ1FFSVQ0V0J6SV92bkpFOUhaVXhOTFhRZnF6UmRpUDNlVERCdDZoTVVJeHZHN2VrRURnamcwU1EyTWhEWmhOOEhieGZMb3owUXlLTVBMWU13Y3VzUVV3bUlCeE9UTHVKa2dhWG40WnZVZUVuNDZfc2dYRTNRY1JiN0oxREt6TlE1UjVxMGNHSzF5YmRiNWFzMnA2MzdKbmtFNEFsN0FEM3FaY3h1SDMxWkxweFUtUy1OZG1SYU9n?oc=5","date":"2026-02-18","type":"pipeline","source":"Fierce Pharma","summary":"J&J fleshes out US investment plan, telegraphing $1B cell therapy plant and 500 new jobs in PA - Fierce Pharma","headline":"J&J fleshes out US investment plan, telegraphing $1B cell therapy plant and 500 new jobs in PA","sentiment":"neutral"}],"patents":[{"drugName":"Duragesic","drugSlug":"fentanyl","patentNumber":"","type":"Patent Cliff","expiryDate":"2023-06-01","territory":"US","annualRevenue":1100000000},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"10406160","type":"Formulation","expiryDate":"2026-06-26","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"10058554","type":"Method of Use","expiryDate":"2026-09-26","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"9597402","type":"Formulation","expiryDate":"2026-09-26","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"11110093","type":"Formulation","expiryDate":"2026-11-05","territory":"US","genericFilings":[]},{"drugName":"Duragesic","drugSlug":"fentanyl","patentNumber":"8835460","type":"Formulation","expiryDate":"2027-01-25","territory":"US","genericFilings":[]},{"drugName":"Duragesic","drugSlug":"fentanyl","patentNumber":"9642797","type":"Formulation","expiryDate":"2027-01-25","territory":"US","genericFilings":[]},{"drugName":"Duragesic","drugSlug":"fentanyl","patentNumber":"9289387","type":"Formulation","expiryDate":"2027-01-25","territory":"US","genericFilings":[]},{"drugName":"Duragesic","drugSlug":"fentanyl","patentNumber":"9241935","type":"Formulation","expiryDate":"2027-01-25","territory":"US","genericFilings":[]},{"drugName":"Duragesic","drugSlug":"fentanyl","patentNumber":"9642844","type":"Formulation","expiryDate":"2027-01-25","territory":"US","genericFilings":[]},{"drugName":"Duragesic","drugSlug":"fentanyl","patentNumber":"8835459","type":"Formulation","expiryDate":"2027-01-25","territory":"US","genericFilings":[]},{"drugName":"Duragesic","drugSlug":"fentanyl","patentNumber":"10610523","type":"Formulation","expiryDate":"2027-01-25","territory":"US","genericFilings":[]},{"drugName":"Duragesic","drugSlug":"fentanyl","patentNumber":"10016403","type":"Formulation","expiryDate":"2027-01-25","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"8221778","type":"Formulation","expiryDate":"2027-11-12","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"8741327","type":"Formulation","expiryDate":"2027-11-12","territory":"US","genericFilings":[]},{"drugName":"Topamax","drugSlug":"topiramate","patentNumber":"9622983","type":"Formulation","expiryDate":"2027-11-16","territory":"US","genericFilings":[]},{"drugName":"Topamax","drugSlug":"topiramate","patentNumber":"8663683","type":"Formulation","expiryDate":"2027-11-16","territory":"US","genericFilings":[]},{"drugName":"Topamax","drugSlug":"topiramate","patentNumber":"8992989","type":"Formulation","expiryDate":"2027-11-16","territory":"US","genericFilings":[]},{"drugName":"Topamax","drugSlug":"topiramate","patentNumber":"8889191","type":"Method of Use","expiryDate":"2027-11-16","territory":"US","genericFilings":[]},{"drugName":"Topamax","drugSlug":"topiramate","patentNumber":"9549940","type":"Formulation","expiryDate":"2027-11-16","territory":"US","genericFilings":[]},{"drugName":"Topamax","drugSlug":"topiramate","patentNumber":"8298580","type":"Formulation","expiryDate":"2027-11-16","territory":"US","genericFilings":[]},{"drugName":"Topamax","drugSlug":"topiramate","patentNumber":"8877248","type":"Formulation","expiryDate":"2027-11-16","territory":"US","genericFilings":[]},{"drugName":"Topamax","drugSlug":"topiramate","patentNumber":"9555004","type":"Formulation","expiryDate":"2027-11-16","territory":"US","genericFilings":[]},{"drugName":"Topamax","drugSlug":"topiramate","patentNumber":"10314790","type":"Formulation","expiryDate":"2027-11-16","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"9186413","type":"Method of Use","expiryDate":"2028-02-13","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"10376590","type":"Method of Use","expiryDate":"2028-02-13","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"11712475","type":"Method of Use","expiryDate":"2028-02-13","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"11013809","type":"Formulation","expiryDate":"2028-02-13","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"10010612","type":"Formulation","expiryDate":"2028-02-13","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"9180197","type":"Formulation","expiryDate":"2028-02-13","territory":"US","genericFilings":[]},{"drugName":"Topamax","drugSlug":"topiramate","patentNumber":"8298576","type":"Formulation","expiryDate":"2028-04-04","territory":"US","genericFilings":[]},{"drugName":"Duragesic","drugSlug":"fentanyl","patentNumber":"8486973","type":"Method of Use","expiryDate":"2030-04-27","territory":"US","genericFilings":[]},{"drugName":"Duragesic","drugSlug":"fentanyl","patentNumber":"8486972","type":"Formulation","expiryDate":"2030-04-27","territory":"US","genericFilings":[]},{"drugName":"Invega Sustenna","drugSlug":"paliperidone-palmitate","patentNumber":"9439906","type":"Method of Use","expiryDate":"2031-01-26","territory":"US","annualRevenue":3800000000,"genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"11752092","type":"Method of Use","expiryDate":"2031-05-31","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"11241377","type":"Method of Use","expiryDate":"2031-05-31","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"11173110","type":"Method of Use","expiryDate":"2031-05-31","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"11007139","type":"Method of Use","expiryDate":"2031-05-31","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"10195138","type":"Method of Use","expiryDate":"2031-05-31","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"10182982","type":"Method of Use","expiryDate":"2031-05-31","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"11759416","type":"Method of Use","expiryDate":"2031-05-31","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"11752094","type":"Method of Use","expiryDate":"2031-05-31","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"10085936","type":"Formulation","expiryDate":"2031-05-31","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"10881605","type":"Formulation","expiryDate":"2031-05-31","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"10058504","type":"Formulation","expiryDate":"2031-05-31","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"10463607","type":"Formulation","expiryDate":"2031-05-31","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"11752093","type":"Formulation","expiryDate":"2031-05-31","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"10335366","type":"Formulation","expiryDate":"2031-05-31","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"10406161","type":"Formulation","expiryDate":"2032-04-10","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"10098882","type":"Formulation","expiryDate":"2032-04-10","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"9532991","type":"Formulation","expiryDate":"2032-04-10","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"9446135","type":"Formulation","expiryDate":"2032-04-10","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"11110094","type":"Formulation","expiryDate":"2032-04-10","territory":"US","genericFilings":[]},{"drugName":"Topamax","drugSlug":"topiramate","patentNumber":"10363224","type":"Method of Use","expiryDate":"2033-03-19","territory":"US","genericFilings":[]},{"drugName":"Topamax","drugSlug":"topiramate","patentNumber":"9555005","type":"Formulation","expiryDate":"2033-03-19","territory":"US","genericFilings":[]},{"drugName":"Topamax","drugSlug":"topiramate","patentNumber":"9101545","type":"Formulation","expiryDate":"2033-03-19","territory":"US","genericFilings":[]},{"drugName":"Topamax","drugSlug":"topiramate","patentNumber":"8889190","type":"Formulation","expiryDate":"2033-03-19","territory":"US","genericFilings":[]},{"drugName":"Topamax","drugSlug":"topiramate","patentNumber":"8652527","type":"Formulation","expiryDate":"2033-03-19","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"9023897","type":"Formulation","expiryDate":"2033-04-05","territory":"US","genericFilings":[]},{"drugName":"Xarelto","drugSlug":"rivaroxaban","patentNumber":"9539218","type":"Method of Use","expiryDate":"2034-02-17","territory":"US","genericFilings":[]},{"drugName":"Xarelto","drugSlug":"rivaroxaban","patentNumber":"9539218*PED","type":"Compound","expiryDate":"2034-08-17","territory":"US","genericFilings":[]},{"drugName":"Invega Sustenna","drugSlug":"paliperidone-palmitate","patentNumber":"12128049","type":"Method of Use","expiryDate":"2038-10-26","territory":"US","annualRevenue":3800000000,"genericFilings":[]},{"drugName":"Invega Sustenna","drugSlug":"paliperidone-palmitate","patentNumber":"11666573","type":"Method of Use","expiryDate":"2039-09-24","territory":"US","annualRevenue":3800000000,"genericFilings":[]},{"drugName":"Topamax","drugSlug":"topiramate","patentNumber":"11433046","type":"Method of Use","expiryDate":"2040-08-21","territory":"US","genericFilings":[]},{"drugName":"Topamax","drugSlug":"topiramate","patentNumber":"12290503","type":"Formulation","expiryDate":"2040-08-21","territory":"US","genericFilings":[]},{"drugName":"Topamax","drugSlug":"topiramate","patentNumber":"11911362","type":"Formulation","expiryDate":"2040-08-21","territory":"US","genericFilings":[]},{"drugName":"Topamax","drugSlug":"topiramate","patentNumber":"11826343","type":"Formulation","expiryDate":"2040-08-21","territory":"US","genericFilings":[]},{"drugName":"Topamax","drugSlug":"topiramate","patentNumber":"11633374","type":"Formulation","expiryDate":"2040-08-21","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"12128132","type":"Formulation","expiryDate":"2040-09-11","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"12383493","type":"Formulation","expiryDate":"2040-09-11","territory":"US","genericFilings":[]},{"drugName":"Risperdal","drugSlug":"risperidone","patentNumber":"12329851","type":"Method of Use","expiryDate":"2042-03-17","territory":"US","genericFilings":[]}],"drugCount":123,"phaseCounts":{"marketed":75,"discontinued":1,"phase_3":38,"phase_1":4,"phase_2":5},"enrichmentLevel":3,"visitCount":4,"keyCompetitors":["Pfizer","Merck & Co.","Eli Lilly and Company"],"therapeuticFocus":["Immunology","Infectious Diseases","Oncology"],"financials":{"source":"sec_edgar","revenue":94193000000,"revenuePeriod":"2025-12-28","revenueHistory":[{"value":94193000000,"period":"2025-12-28"},{"value":88821000000,"period":"2024-12-29"},{"value":88821000000,"period":"2024-12-29"},{"value":85159000000,"period":"2023-12-31"},{"value":85159000000,"period":"2023-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":109000000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":26804000000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":199210000000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":237.67,"previousClose":238.41,"fiftyTwoWeekHigh":251.71,"fiftyTwoWeekLow":141.5,"fiftyTwoWeekRange":"141.5 - 251.71","fiftyDayAverage":239.35,"twoHundredDayAverage":198.85,"beta":0.33,"enterpriseValue":603774976000,"forwardPE":18.9,"priceToBook":7.02,"priceToSales":6.08,"enterpriseToRevenue":6.41,"enterpriseToEbitda":17.84,"pegRatio":1.7,"ebitda":33835999232,"ebitdaMargin":35.9,"freeCashflow":16633249792,"operatingCashflow":24529999872,"totalDebt":49332998144,"debtToEquity":60.5,"currentRatio":1.03,"returnOnAssets":8.7,"returnOnEquity":35,"analystRating":"2.1 - Buy","recommendationKey":"buy","numberOfAnalysts":24,"targetMeanPrice":241.25,"targetHighPrice":280,"targetLowPrice":155,"dividendRate":5.2,"payoutRatio":0.47,"fiveYearAvgDividendYield":2.77,"exDividendDate":1771891200,"insiderHeldPercent":0.1,"institutionHeldPercent":75.7,"sharesOutstanding":2408613219,"floatShares":2406091296,"sharesShort":23327094,"shortRatio":2.67,"shortPercentOfFloat":1,"epsTrailing":11.04,"epsForward":12.57,"revenuePerShare":39.13,"bookValue":33.87,"officers":[{"age":62,"name":"Mr. Joaquin  Duato","title":"CEO & Chairman"},{"age":61,"name":"Ms. Jennifer L. Taubert","title":"Executive VP & Worldwide Chairman of Innovative Medicine"},{"age":67,"name":"Dr. John C. Reed M.D., Ph.D.","title":"Executive Vice President of Innovative Medicine and R&D"},{"age":55,"name":"Mr. Timothy  Schmid","title":"Executive VP & Worldwide Chairman of MedTech"},{"age":52,"name":"Mr. Robert J. Decker Jr.","title":"Controller & Chief Accounting Officer"},{"age":58,"name":"Mr. James  Swanson","title":"Executive VP & Chief Information Officer"},{"age":null,"name":"Mr. Darren  Snellgrove","title":"Vice President of Investor Relations"},{"age":null,"name":"Mr. Dirk  Brinckman","title":"Chief Compliance Officer"}],"industry":"Drug Manufacturers - General","irWebsite":"http://www.investor.jnj.com/investor-relations.cfm","website":"https://www.jnj.com","phone":"732 524 0400"}}